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Abstract 
Bovine Respiratory Disease Complex (BRDC) is the most common and costly disease in feedlot 
cattle in North America. Annual economic losses are estimated to be US$1 billion due to 
mortality, reduced performance, and treatment costs.  The disease is a multifactorial syndrome 
caused by a combination of environmental factors, management practices, animal susceptibility, 
and viral and bacterial pathogens. The objectives of this dissertation were to evaluate two 
injectable antimicrobials for the treatment and control of BRDC in feedlot cattle, investigation of 
factors associated with BRDC mortality and morbidity, and to develop control charts based on 
statistical process control (SPC) principles to monitor cattle mortality rates.  
Two multi-site prospective studies were conducted to evaluate the comparative efficacy of the 
administration of gamithromycin and tulathromycin for the treatment and control of BRDC. A 
total of 2,529 animals were enrolled at two commercial feedlot locations to evaluate the efficacy 
of the antimicrobials to control BRDC. Morbidity due to BRDC was higher (P = 0.03) among 
calves receiving gamithromycin compared with those receiving tulathromycin; however, 
treatments were considered bioequivalent (P < 0.05) for BRDC mortality, case fatality rate and 
re-treatment rate. Final BW, ADG, DMI and F:G, were similar (P<0.05) between the groups of 
calves receiving gamithromycin and tulathromycin. For the evaluation of treatment efficacy, a 
total of 1,049 calves were enrolled in the study. Re-treatment rate was higher among animals 
treated with gamithromycin compared with those treated with tulathromycin. Treatments were 
bioequivalent (P < 0.05) for case fatality rate, final BW, and ADG.  
To evaluate factors associated with BRDC, a retrospective study was conducted to analyze 
BRDC mortality and morbidity associated with initial body weight, rectal temperature, and 
  
castration and dehorning (tipping) at processing. Calves with lighter weights and fever at 
processing were at greater risk of mortality and morbidity due to BRDC. Also, bulls castrated at 
processing were at higher risk of developing BRDC.  Finally, we developed control charts based 
on SPC principles to monitor and identify “normal” and special cases of variation of mortality 
rate. In feedlot cattle, monitoring lots of cattle through SPC principles can be used as a powerful 
tool for continuous improvement. 
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re-treatment rate. Final BW, ADG, DMI and F:G, were similar (P < 0.05) between the groups of 
calves receiving gamithromycin and tulathromycin. For the evaluation of treatment efficacy, a 
total of 1,049 calves were enrolled in the study. Re-treatment rate was higher among animals 
treated with gamithromycin compared with those treated with tulathromycin. Treatments were 
bioequivalent (P < 0.05) for case fatality rate, final BW, and ADG.  
To evaluate factors associated with BRDC, a retrospective study was conducted to analyze 
BRDC mortality and morbidity associated with initial body weight, rectal temperature, and 
  
castration and dehorning (tipping) at processing. Calves with lighter weights and fever at 
processing were at greater risk of mortality and morbidity due to BRDC. Also, bulls castrated at 
processing were at higher risk of developing BRDC.  Finally, we developed control charts based 
on SPC principles to monitor and identify “normal” and special cases of variation of mortality 
rate. In feedlot cattle, monitoring lots of cattle through SPC principles can be used as a powerful 
tool for continuous improvement. 
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Chapter 1 - Literature Review 
 Introduction 
 
Bovine respiratory disease complex (BRDC) is the most common and costly disease in the beef 
cattle industry in North America
23,41,64
. According to the National Animal Health Monitoring 
System (NAHMS) from the United States Department of Agriculture (USDA), BRDC is the 
primary cause of illness and death in feedlot cattle
72
. It is estimated that BRDC accounts for 
approximately 50% of morbidity and over 75% of mortalities in the feedyards
4
. Economic losses 
are due to mortality, reduced performance, treatment costs, and decreased carcass quality 
23,41,64
. 
BRDC is a multifactorial syndrome caused by a combination of environmental factors, 
management practices, animal susceptibility, and viral and bacterial pathogens
20,41,68
. Extensive 
research on BRDC pathogenesis, diagnosis, prevention, and control measures has been 
conducted; however, BRDC morbidity and mortality rates have been increasing in recent years
20
.  
Currently, the administration of single dose, injectable antimicrobials have shown to be the most 
efficacious tool for control and treatment of the disease
5,25,29,45,74
. The objective of this literature 
review on Bovine Respiratory Disease Complex BRDC is to review the epidemiology, economic 
impact, preventive methods to control, and treatment of BRDC in feedlot cattle. In addition, 
briefly discuss the potential benefit of Statistical Process Control (SPC) as a tool to monitor 
animal health in beef cattle. 
 The epidemiologic triad of bovine respiratory disease complex 
Animal health status is determined by the balance between protective factors (animal resistance) 
and risk factors (challenge of disease)
30,68
.  This balance depends on the interaction among the 
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susceptible host, etiologic pathogens, and the environment: the three components of the 
epidemiologic triad. The development of BRDC has been associated with environmental factors, 
management practices, animal susceptibility, and viral and bacterial pathogens
41,45
. Stressful 
management practices (e.g. weaning, castration, transportation, commingling, etc.) promote the 
transmission and proliferation of commensal, but potentially pathogenic, microbes located in the 
nasopharynx of healthy cattle
3,12,24
. Viral and bacterial agents proliferate, become pathogenic, 
and damage the respiratory tract during the progression of subsequent respiratory disease
3,24,46
 .   
The clinical expression of BRDC varies according to the animal, the level of stress that animal 
experiences, management practices prior to and after the marketing process, and level of 
pathogen challenge
56,62-64,66
. 
 Pathogens involved in the development of bovine respiratory disease complex 
Pathogens involved in the development of BRDC include viruses and bacteria that act in a 
synergistic manner which results in bacterial pneumonia
2,16,26
. Viruses play an important role in 
the development of bacterial pneumonia since they predispose the animal’s lung to bacterial 
infection by causing direct damage to the respiratory mucosa and lung parenchyma and inhibit 
the animal’s defense mechanisms against bacteria that are commensal in the upper respiratory 
tract
26,68
. The major viruses involved in precipitating BRDC are: Bovine herpesvirus-1 (BHV-1) 
(Infectious Bovine Rinotracheitis); Parainfluenza Virus-3 (PI3); Bovine Respiratory Syncytial 
virus (BRSV), and Bovine Viral Diarrhea Virus (BVDV).  The latter organism has been 
recognized as a major pathogenic partner associated in the development of BRDC
24,46
.  In 
addition, Bovine respiratory coronavirus has also been identified as a viral pathogen involved in 
the development of BRDC; however, the importance as a major virus is still under 
investigation
46
.   
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Even though viral agents can produce clinical signs consistent with BRDC without bacterial 
infection, naturally occurring BRDC generally is considered to involve concurrent infection with 
bacteria
26,68
. Indeed, one highly effective experimental model for development of BRDC 
involves the exposure to Mannheimia haemolytica after infection with bovine herpesvirus-1 
(BHV-1)
28,68
. Bacterial pathogens involved in the development of BRDC include Pasteurella 
multocida, Mannheimia haemolytica (formerly Pasteurella haemolytica), Histophilus somni 
(formerly Haemophillus somnus), and Mycoplasma bovis
12,23,24,46
. Although all these bacteria 
have been implicated as primary pathogenic agents in BRDC, Mannheimia haemolytica has been 
considered the most important bacterial pathogen in precipitating the disease.  These bacteria are 
considered commensals of the upper respiratory tract and nasopharynx; however, stress and viral 
infection are predisposing factors for the bacterial infection in the lower respiratory tract
3,12,24
.  
Bacterial virulence factors include adhesins, capsular polysaccharide, outer membrane proteins, 
iron-binding proteins, lipopolysaccharides and lipo-oligosaccharides, enzymes, and toxins
12,24
. 
These virulence factors are important in the pathogenesis of the disease because allow bacterial 
attachment and proliferation in the respiratory mucosa in the lower respiratory tract
12,24,46
.  In 
addition, these factors cause severe inflammation, damage to the immune system, and 
destruction of the lung tissue
12,22,24,46
.  
Other bacterial pathogens associated with BRDC include Arcanobacterium pyogenes, Birbistenia 
threalosi, and other species of Pasteurella and Mycoplasma
24
; however, the importance of these 
pathogens has not been established. 
 Predisposing factors associated with environment 
Environmental predisposing factors, other than viral and bacterial pathogens, are necessary to 
induce naturally occurring BRDC. Several predisposing factors, also referred as “stressors”, have 
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been postulated to be associated with the development of the disease
3,4,68
. These factors include: 
transportation, weaning practices, weather conditions (cold, cold combined with wet conditions, 
and sudden and extreme changes in ambient temperature), transportation, commingling with 
unfamiliar animals, handling, painful procedures such as castration and dehorning, malnutrition, 
and acute metabolic disorders
2,8,16,26,43,68
. 
 Transportation 
Transportation is the most well-recognized predisposing factor for BRDC, and it has been 
associated with the disease for decades; indeed, this environmental factor led to the common 
denomination of the disease as “shipping fever”66,68. 
Transportation has been associated with stress, and causes an increase in circulating 
glucocorticoids 
2,66
. Glucocorticoids are linked to immunosuppression leading to an increase in 
infectious disease susceptibility 
2,16,66
.  Even though practically all the beef cattle in the United 
States are transported at least once in their entire life, not all transported cattle develop BRDC. 
One study, conducted under experimental circumstances, reported that animals transported for 
12hr had higher morbidity rates compared with animals transported for 24hrs, and the study 
concluded that other factors such as sorting, loading, and early transit are most likely to be 
associated with the development of BRDC than hours of transit 
53
.  However, recent studies 
reported a significant association between body weight loss during transportation and BRDC 
morbidity and overall mortality in feeder cattle, and associations between transportation and 
increase of stress biomarkers related to episodes of BRDC morbidity and mortality
8,9
. These 
studies concluded that stress related to transportation is involved in the development of the 
disease
68
. 
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 Weather 
Weather has been linked to the development of BRDC, and the highest incidence of BRDC is 
normally observed during the season of fall
34
. During this time of the year, cattle are typically 
weaned and marketed through auction markets for further shipment to the feedyards.  This 
seasonality increases cattle traffic through auction markets which leads to an increase in time that 
cattle spend in stockyards, and potentially delays the loading and unloading processes.  These 
changes in normal marketing logistics may contribute to increased stress, dehydration, and 
susceptibility to disease
66,68
.  In addition, this situation increases cattle commingling and 
exposure to infected animals that are spreading viral and bacterial pathogens to the 
immunosuppressed population.  
Even though it has been postulated that sudden and extreme changes in weather conditions 
predispose to BRDC, more research is needed to determine the effect of this extreme sudden 
change in weather conditions on BRDC
68
. 
 Castration and dehorning 
Castration of bulls is performed to reduce aggression and mounting behavior of males; in 
addition, castration has shown to improve beef quality
7, 11, 82
. Therefore, castration is a common 
practice in the US beef industry standards
11
. It is recommended to castrate bull at early life to 
reduce economic losses due to reduced performance, and improve animal welfare
7,42
. In the 
feedlot industry, castration of intact bulls is an intervention performed at processing upon arrival.  
It is a painful procedure that has shown to increase plasma cortisol and haptoglobin 
concentrations, and decrease gamma-interferon production resulting in animal 
immunosuppression
10,18
, and animals may be at greater risk of developing infectious diseases
11
.  
Consequently, it is believed that intact bulls that are castrated at feedlot arrival are at greater risk 
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of developing BRDC
18,82
; nevertheless, evidence has been incostintent
68
 . One study evaluating 
the effect of castration on health and performance (n=105 calves) reported that reported that 
morbidity (animals that were pulled) and treatments were significantly higher (P ≤ 0.03) in 
calves that were castrated surgically compared with those that were purchased as steers. 
However, in another experiment (n=283 calves), no evidence of differences (P ≥ 0.22) in first 
treatment or retreatment rates were found between calves that were purchased as steers, or bulls 
that were banded or surgically castrated
6
. Another study reported that castrated bulls had 
marginally greater overall morbidity rates and BRDC incidence rates compared with steers
10
. 
Dehorning is a management practice performed at processing after cattle arrives to the feedyard.  
Dehorned cattle are safer to handle and reduce hide damage and carcass bruises
65
. Like 
castration, dehorning is a painful procedure that increases plasma cortisol resulting in 
immunosuppression
65,69
. Dehorning has shown to have negative impact in cattle 
performance
6,16,35,82
. In addition, dehorning has shown to affect negatively cattle health; indeed, 
it has been reported that dehorning can increase morbidity rate by 30% compared with non-
dehorned animals
39
.   
 Individual animal susceptibility 
It has been postulated that individual animal factors are associated with susceptibility or BRDC. 
These individual factors include gender, age or weight, genetics, and behavior.  
 Gender 
Although it is believed that steers are at higher risk of developing BRDC compared to heifers, 
there is no conclusive evidence in the literature about the effect of gender on BRDC morbidity or 
mortality in feeder cattle. For instance, one study reported that from 1994 to 1996, steers and 
heifers had the same risk of mortality due to BRDC; however, mortality rates were higher in 
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heifers compared to steers from 1997 to 1999
34
. Other studies have reported that steers were at 
higher risk of developing BRDC compared to heifers; nonetheless, authors concluded that this 
finding can be confounded by management practices performed only in males (e.g. castration of 
intact bulls)
64,68
.  
 Weight at arrival 
Many studies have reported that calves which are lighter upon feedlot arrival are at higher risk of 
developing BRDC compared with heavier cattle
56,69
. One study reported that calves weighing 
less than the average weight were 1.4 times more likely to develop BRDC compared with those 
weighing more than the average weight. Likewise, a study analyzed BRDC incidence during 12 
weeks in 122 pens of feedlot cattle, and reported that heavier arrival weights were associated 
with decreased morbidity risk
56
. Cattle weight at arrival can be a good predictor of BRDC 
mortality and morbidity in feedlot cattle, and can be used to categorize animals into risk groups; 
then, management and economic decisions based on risk assessment can be conducted
56
. 
 Genetics 
Even though heritability of BRDC susceptibility has been postulated, it has been reported to be 
very low. Instead, susceptibility to BRDC seems to varies among different cattle breeds
63,68
.  The 
breeds Bos taurus are more susceptible to develop BRDC compared to Bos indicus breeds, and 
within Bos taurus, Hereford animals seems to be at higher risk of developing BRDC compared 
with other breeds
63
. 
 Clinical signs associated with bovine respiratory disease complex 
Severity of clinical signs of BRDC varies from unapparent to per-acute death 
12,24
. When clinical 
signs are observed, they are usually evident between 7 to 10 days after the stressful situation; 
however, in newly received cattle, clinical signs can be present as late as 27 days after 
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arrival
24,81
.  Typical clinical signs include depression and anorexia, nasal and ocular discharge, 
fever, increased respiratory rate, and moist cough.  Depending on the severity of anorexia, 
animals can experience slight to severe weight loss
81
.  At auscultation, lungs reveal vesicular and 
bronchial cranial-ventral sound that progress to laud bronchial tones indicating consolidation that 
are moist in early stages and become dry in advanced conditions. Finally, animals may stand 
with abducted elbows and extended neck to increase ventilation and pulmonary capacity; in 
some cases, animals can present diarrhea
81
.  
Diagnosis of morbid animals is commonly based on the DART system (Pharmacia Upjohn 
Animal Health, Kalamazoo, MI) or modifications
20
. The system consists of clinical evaluation 
and scoring of depression, appetite, respiration, and temperature. Diagnosis of BRDC under field 
conditions is difficult because beef cattle exhibit prey behavior and perceive care personnel (e.g. 
pen riders) as predators. Consequently, sick animals often mask clinical symptoms; thus, 
delaying early detection and treatment
24,50
. 
Typically, diagnosis of BRDC is based on a combination of objective (i.e. rectal temperature, 
body weight) and subjective (i.e. depression, abnormal appetite, and respiratory signs) 
assessments of morbid animals
67
; nevertheless, there is a high degree of diagnostic error. Indeed, 
previous studies have shown that diagnosis of BRDC based on DART attributes has sensitivity 
and specificity rates of 61.8 and 62.8% respectively
77
.  One study conducted in South Africa 
reported that only 55.4% of animals treated once for BRDC had lung lesions at slaughter
71
.  
Similarly, another study found that only 78% of steers treated for respiratory disease (either 
before weaning or in the feedlot) had lung lesions at slaughter
79
. Consequently, large proportion 
of false-positives and false-negatives can bias assessments of morbidity rates. Hence, clinical 
scores and lung lesions at slaughter seems to be poor methods to accurately detect diseased 
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animals
77
.  New technologies that increase the sensitivity and specificity of BRDC diagnosis are 
needed to increase accuracy in evaluating morbidity rates feeder cattle. 
 Economic impact of bovine respiratory disease complex 
Bovine respiratory disease is the most costly and common disease in beef cattle in North 
America; it has been estimated that annual economic losses due to BRDC are US $1 billion due 
to due to morbidity, mortality, treatment cost, and reduction in performance and carcass 
value
22,23,41,45,58
. In addition, it is estimated that over US$3 billion are spent annually on 
preventive measures for BRDC in beef cattle
23
. One study reported that on an individual live-
animal basis, the economic losses associated with lower body weight gain and treatment cost for 
BRDC infection was $13.90 per animal; this study evaluated 18,112 calves from 1987 to 2001
64
.  
Likewise, another study analyzed health records from 5,975 animals in combination with lung 
lesions at slaughter, and reported that BRDC incidence decreased ADG by 0.07 kg per animal 
per day, reduced hot carcass weight by 8.16 kg, and reduced marbling score.  The economic loss 
due to reduced performance and negative impact on carcass traits was estimated at $23.23, 
$30.15, and 54.01 for animals that were treated once, twice or three times, respectively
58
.  
Another assessment of the economic impact of BRDC was conducted by the Ranch to Rail 
program conducted by Texas A&M
40
. Data from this program showed that BRDC was 
associated with higher production cost, lower feedlot performance, and lower USDA quality 
grade.  According to these data, animals that had at least one treatment for BRDC returned 
$92.26 less than animals that remained healthy through the entire feeding period
40
. In another 
study conducted in 2007, feedlot animals were segregated according to the number of BRDC 
treatments received during the first 63 days of feed; subsequently, animals were grouped in pens 
according to the number of treatments received: 0, 1, 2, or 3 treatments for BRDC, or deemed as 
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chronic. Then, all calves were fed until they reached a similar ultrasound fat-content endpoint.  
The study reported no evidence of BRDC differences on carcass traits, beef tenderness, or 
palatability. Likewise, no evidence of differences in final body weight was found among animals 
that received 0, 1, 2 or 3 treatments for BRDC. The number of days on feed required to reach the 
same endpoint were different among treatment groups, so animals that received 0 or 1 treatment 
for BRDC were slaughtered on day estimated of 162, and calves that received 2 or 3 treatments 
had estimated days on feed of 182 and 189, respectively
27
. This study concluded that regardless 
of number of treatments for BRDC, animals appear to maintain the potential to produce 
carcasses with similar characteristics as healthy animals; however, additional days on feed are 
required to reach this endpoint
27
. From an economic standpoint, losses due to BRDC, based on 
this model, involve only treatment costs and approximately 18 additional days on feed, and no 
negative effect on carcass merit. 
 Preventive measures 
In an effort to minimize the negative effects of BRDC, the beef industry has developed several 
pre-arrival and post-arrival interventions known as preventive measures. The most common 
interventions include preconditioning, vaccination, health protocols at processing (including 
metaphylaxis), and nutrition management
69
. 
 Preconditioning 
The concept of preconditioning was first described in 1965 by Dr. John Herrick, and it is 
considered a pre-arrival practice to reduce mortality and morbidity in the feedyard by 
strengthening animals’ immunity, preventing stressors involved in the marketing process, and 
increasing animal resistance to pathogen
16,76
. Even though preconditioning protocols are not 
well-defined and include multiple variations of interventions, the common components of 
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preconditioning include castration and dehorning at early life, administration of respiratory and 
clostridial vaccinations, deworming, weaning approximately 30-45 days prior to shipping, and 
training to eat from a feed bunk and drink from water tanks
16,69,76
.  
The benefits of preconditioning were questionable two decades ago because of the lack of 
consistent results reported in the literature; however, in the last few years, large randomized 
control trials have shown that this practice is valuable, improving health and performance in 
feedlot cattle
69
. One study conducted in Canada with 12,313 calves reported that calves which 
were vaccinated and conditioned prior to shipment were less likely to receive treatment for 
BRDC in the feedlot during the first 28 days after arrival compared with calves acquired from 
conventional auction markets
36
. Another study including 273 calves originated from unknown 
sources or two different preconditioning programs reported that preconditioned animals had 
higher ADG, better feed conversion, and lower morbidity and mortality ratios in feeder cattle; 
this study reported that the added value of calves that were preconditioned compared with those 
with unknown origin was between $46.83 and $49.54 per animal
55
. 
Despite the evidence of preconditioning programs in improving health and performance in beef 
cattle, the adoption of this valuable tool is very low in cow-calf operations
76
. Furthermore, the 
lack of vertical coordination within the US beef industry makes it difficult to implement this type 
of program because of misunderstanding of the economic value for both cow-calf and feedlot 
operations
69
.  It is important for the beef industry to increase the adoption of this practice to 
improve performance, health and well-being of beef cattle. 
 Processing protocols 
Upon arrival to the feeding facility, beef cattle are subject to a series of procedures commonly 
known as processing.  Processing typically includes weighing and giving an ear tag for animal 
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identification, administration of vaccines, parasiticides, antimicrobials, and anabolic implants, 
castration of intact bulls, dehorning, and administration of an abortificant to pregnant heifers; in 
some cases, administration of injectable vitamins and minerals and oral administration of direct 
fed microbials is also practiced
69
. Processing practices are aimed at improving health and 
performance, and minimizing morbidity and mortality of animals at risk of developing 
respiratory disease. 
 Time of processing 
Effect of time of processing after arrival on animal health has been discussed for many years; 
however, there is not conclusive evidence about effects attributable to timing of processing
69
. In 
a feedlot consultant survey conducted to 23 veterinarians in north-America, the majority of 
veterinarians (91%) require that long-hauled (defined as greater than 8 hours) animals be allowed 
an extended period of rest (between 12 to 24 hours) before processing, and for those animals 
subjected to short hauls (defined as less than 8 hours), veterinarians (74.8%) require that animals 
rest less than a 6 hour period
70
. Since there are countless variations in processing protocols, no 
conclusive evidence is available pertaining to the effect of processing on BRDC morbidity and 
mortality. Further research with randomized control field trials and standardize processing 
protocols will help to determine the proper timing for processing high-risk and low-risk calves. 
 Vaccination at arrival 
Respiratory vaccination at arrival against bacterial pathogens, viral pathogens, or both, is 
common among practically all feeding facilities
69,72
. According to the USDA, vaccination 
administered at processing includes antigens against BVD (94.4%), IBR (96.9%), PI3 (86.3%), 
BRSV (87.4%), Histophillus somni (62.1%), and Pasteurella spp (55.3%)
72
. A feedlot consultant 
survey conducted to 23 veterinarians revealed that all consultants recommend vaccination for 
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high-risk calves at processing against IBR and BVD Types I and II; in addition, 65.2%, 60.9% , 
21.7% and 73% of the veterinarians recommend vaccination against BRSV, PI3, Histophilus 
somni, and Mannheimia haemolytica, respectively
70
. Surprisingly, there is little information in 
the literature that supports this practice in reducing BRDC morbidity and mortality
54
. Besides, it 
was hypothesized that vaccination at arrival may be a detrimental practice because animals are 
stressed, already exposed to pathogens, and perhaps experiencing immunosuppression 
54
. In a 
study conducted in Ontario, vaccination at arrival increased morbidity and mortality in feedlot 
cattle
37
. Also, a review of respiratory vaccination at arrival concluded that most vaccines 
administered at processing are ineffective in preventing BRDC
38
.  It can be argued that these 
conclusions are not valid because they were done in the 1980’s, and vaccines currently available 
are different
20
. Unfortunately, no additional research has been conducted to evaluate the efficacy 
of vaccination in preventing BRDC.  In recent years, research has focused on comparing 
different multivalent modified live vaccine protocols using different antigen strains, and these 
studies do not include negative control groups
19,20,61,69,78
. Therefore, it is not possible to 
determine the efficacy of vaccination at arrival in preventing BRDC. More research must be 
conducted in order to determine effective respiratory antigen immunization protocols for feedlot 
cattle. 
 Health monitoring parameters 
In the modern feedlot industry, population based medicine is one approach that allow consultants 
to study interactions among health and productivity.  A clear definition of health outcomes that 
can be monitored is critical for the success of the health program in the feeding operation
13
. 
From epidemiological perspective, incidence and prevalence are the most used health outcomes 
in the feedlot industry
13
.  Incidence is the probability that an individual animal will develop the 
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disease in a defined period of time, and it refers to the number of new events, in a defined 
population within a specific period; prevalence is related to all the cases of disease existing at 
specific point in time in a population rather than new cases occurring over a period of time
15
. 
Incidence is normally calculated as the number of new cases of disease in a certain period of 
time divided by the total number of animals that were at risk at the beginning of the time period.  
The formula to calculate prevalence is the number of animals in the population with the disease 
at a certain point of time divided by the total number of animals in the population at that certain 
point of time
15
.  In the cattle feeding industry, health outcomes commonly measured include: 
morbidity, mortality, case fatality, re-treatment, and chronic animals (non-responders).  Usually, 
these outcomes are expressed in terms of incidence
13
. 
Mortality rate is obtained by dividing the number of calves that died during a time period by the 
number of calves in the group that was at risk (population at risk). In feeder cattle, the number of 
animals that arrived (per each lot of cattle or over the entire cattle population) is typically used as 
population at risk.  The period of time can be determined by the veterinarian consultant, and it 
usually is conducted by month, year, season, or at close-out
13
. 
Case fatality rate, a measure of mortality, is referred to as the percentage of animals that died 
among those that were identified as having the specific disease.  Case fatality rate is calculated 
by dividing the number of animals that died by the number of animals that were identified as 
diseased during a certain period of time
13
. 
Re-treatment rate refers to the proportion of calves that required a second treatment for the same 
disease for which they were previously treated
15
.  It is calculated by dividing the number of 
animals that required a second treatment by the number of calves that received the initial 
treatment during a certain period of time.  Further treatments rates can also be determined 
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following the same rationale for re-treatment rate.  Percentage of chronic animals, also called 
non-responders, is calculated by dividing the number of calves that did not responded to therapy 
(also known as realizers) by the total number of calves that received the initial therapy during a 
certain period of time
13
. 
 Metaphylaxis to control bovine respiratory disease complex 
Metaphylaxis, also referred as control, consists of mass administration of an approved 
antimicrobial in an animal population that is at imminent risk of developing disease, before the 
onset of illness
16,45
. The goal of metaphylaxis is to address the bacterial infection in the 
respiratory tract of stressed animals which may have a compromised immune system
45
. In beef 
cattle, it was first reported in the early 1980’s using the mass administration of injectable 
oxytetracycline on feedlot calves to reduce the incidence of BRDC
32,33
; later, several studies 
administering a single dose of injectable tilmicosin demonstrated to be efficacious in controlling 
BRDC in feeder cattle
21,44,59,60,73
. 
Studies have shown that metaphylaxis improves health and performance of high risk calves; it 
decreases BRDC morbidity and mortality; in addition, metaphylaxis has shown to increase 
average daily gain and feed efficiency compared with negative controls
45
. In the US, single dose 
injectable antimicrobials approved for metaphylaxis include oxytetracycline, tilmicosin, 
florfenicol, ceftiofur crystalline free acid, tulathromycin, and gamithromycin
5,21,29,31,33,47
. The 
selection of an antimicrobial in commercial settings is usually based on the characteristics of the 
drug, expected drug efficacy, and cost
45
. 
Comparative drug efficacy among drugs approved for BRDC control is normally determined by 
evaluating animal health and performance following metaphylaxis.  Tulathromycin and 
tilmicosin have the greatest number of clinical trials for controlling BRDC reported in the 
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literature; comparisons against florfenicol, ceftiofur crystaline free acid (CCFA), and 
oxytetracycline have been conducted.  Health outcome definitions vary among studies, so it is 
very difficult to establish a conclusive antimicrobial efficacy rate.  For instance, 3 out of 12 
studies didn’t report mortality or morbidity rates, and the range for which health outcomes were 
evaluated was from 10 to 60 days on feed, so there is not a unique criteria established to evaluate 
health and performance.  Finally, differences in health outcomes show that cattle enrolled in the 
studies were at different levels of risk, originated from different geographical locations, and were 
subjected to different processing protocols and management practices. The variability of risk 
factors for cattle makes difficult to conclude on absolute and relative efficacy of antimicrobials 
for metaphylaxis. 
 Treatment of bovine respiratory disease complex 
A successful therapy program includes the following items: identification of disease challenges, 
case definition for sick animals, complete description of treatment protocol (dose, route/site of 
administration, frequency, volume, withhold, etc.), success/failure case definition, potential re-
treatment protocols, and a system to monitor health outcomes. 
Case definition for BRDC can vary among veterinary consultants; however, it usually includes a 
combination of clinical observations based on the DART system (Depression, Appetite, 
Respiration score, and Temperature). An example of case definition for BRDC includes calves 
showing respiratory clinical scores of 1 or 2 and having rectal temperature ≥ 104ºF, or animals 
showing clinical scores of 3 regardless rectal temperatures (Table-1).  Animal health personnel 
should be well trained on case definitions for accurate diagnosis and early sick animal 
identification
17
.  Cattle are prey animals that hide clinical signs as a means of self-preservation, 
which makes identification of sick animals difficult and imprecise.   
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Once animals are suspected to be suffering from BRDC in the home pen, it is recommended that 
further evaluations be done to confirm diagnosis.  Confirmation should be done by experienced 
animal health personnel using diagnostic tools such as rectal thermometer and stethoscope for 
lung auscultation. 
Written treatment protocols developed by a veterinarian should include the name(s) of the animal 
health product(s), dosage, route of administration, and withdrawal date.  Animal health products 
have to be administered according to the label directions and following the Beef Quality 
Assurance guidelines from the National Cattlemen’s Beef Association (NCBA). Antimicrobial 
use at a different dosage rate or different route is considered as “extra-label” use, and it is not 
approved by governmental agencies. 
Antimicrobial consideration for initial therapy, including first and consecutive treatment 
regimen, involves potential interaction for sequential administration of antimicrobials
3
. 
Injectable antimicrobials labeled for treatment of animals diagnosed with BRDC include: 
tulathromycin, tildipirosin, CCFA, oxytetracycline, florfenicol, tilmicosin, enrofloxacin, 
danofloxacin, ceftiofur hydrochloride, ceftiofur sodium, spectinomycin sulfate, penicillin G, and 
ampicillin.   
Post-treatment interval (PTI), or moratorium, is the period of time between last antibiotic 
treatment and further treatments.  The suggested PTI varies according to each antimicrobial’s 
pharmacokinetics
3
. Ancillary therapy for BRDC includes, but is not limited to: anti-
inflammatories (steroidal and non-steroidal), vitamins, antihistamines, immuno-modulators, 
diuretics, and bronchodilators.  These concurrent medications may substantially increase the cost 
of treatment, and there is no evidence in the literature supporting these practices in improving 
health outcomes or performance
3
. One study comparing antimicrobial treatment concurrent with 
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and without non-steroidal anti-inflammatory (e.g. flunixin meglumine, carprofen and ketoprofen) 
reported no evidence of differences among treatment groups in reference to clinical depression, 
illness scores, dyspnea, or coughing.  Nevertheless, the authors reported reduced lung 
consolidation at necropsy among those animals that received flunixin meglumine.  
After treatment protocol administration, animals may either be returned to their home pen for 
recovery or be assigned to a hospital pen.  Animals have to be observed daily for clinical 
evaluation and determine recovery signs.  Home pens should provide animal well-being and feed 
and water ad libitum. Animals that fail to respond to therapy have to be re-evaluated by qualified 
animal health personnel; if necessary, they will be deemed as non-responders and categorized as 
chronic. 
 Statistical process control 
Statistical Process Control (SPC) is a powerful tool for monitoring, controlling, and improving 
processes and outcomes through statistical methods
51
.  Even though this tool has been used for 
more than 80 years in the manufacturing and human health care industries, its application in food 
animal agriculture has not been extensively implemented
52
. Production systems in food animal 
agriculture are based on standardized operating procedures (SOP) and management practices 
than can be monitored using statistical methods
52
; therefore, SPC can be used for monitoring 
SOP outcomes, health outcomes and animal performance; hence, top management and animal 
care personnel can easily identify abnormal deviations and make early interventions to return 
animals to normal. 
Statistical process control was developed during the 1920’s by statistician Walter A. Shewarth; 
later, SPC was popularized by Edward W. Deming for use, first in military-industrial 
manufacturing in the U.S. war effort, and later by post-war Japanese industrial firms
51
 
19 
 
 In livestock, the initial published information about the use of SPC was in the swine 
industry in 1977
80
.  In the cattle industry, SPC has been implemented in dairies as a method to 
monitor and control mastitis, milk quality, bulk-tank milk somatic cell counts, and reproductive 
performance
14
.  In beef cattle, SPC has been reported to monitor carcass quality
48
, steer weight 
gain
57
, and feeding behavior of newly received calves
49
.  However, to our knowledge, no 
additional SPC reports on beef cattle health have been published. 
Animal performance is critical to assure profitability and sustainability. Beef cattle operations 
measure productivity based on the efficiency on how capital, labor, energy, and commodities are 
transformed into the final product
14
. Feedlot profitability is affected by economic losses due to 
animal health conditions and/or animal performance deviations
14
.  Developing an SPC system to 
monitor, evaluate and analyze health and performance otucomes in feedlot cattle will provide an 
easy-to-use tool to identify and differentiate between “normal” and “special” cases variation.  
Hence, veterinarians and other cattle care personnel can implement quick interventions to reduce 
the impact of potential losses, return animals to normal, and improve animal health and 
productivity.  
Even though record keeping is a common practice in feedlot operations, it does not imply that 
actions will be, or should be, taken to improve health and performance. Experience has shown 
that SPC principles, in conjunction with other management practices, can be applied in feedlot 
production medicine and can become a very powerful tool for continuous improvement
52
.  
 Control charts 
Control charts are one of the most important SPC tools for monitoring and analysis.  The 
foundation of control charts pertain to the theory of variation, understanding and defining what 
“normal” variation is, and identifying “special cases” of variation1.  Control charts combine time 
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series methods with graphical representation of data, they have a center line and corresponding 
upper and lower control limits.  The center line represents the overall mean (central tendency) of 
the observations, and the control limits are estimated using the standard deviation (sigma) 
technique
51
. The placing of control limits will depend on each individual observation and the 
level of type I and type II errors
51
.  A robust control limit uses 3-sigma units from the mean
75
.  
Nevertheless, other considerations based on previous experience, feedlot targets, and statistical 
adjustments for binomial distributed data, can be used to properly define control limits. 
Statistical process control represents an invaluable opportunity to improve herd management and 
profitability
14
. In the feedlot industry, veterinarians and cattle care providers can take advantage 
of this easy-to-use and powerful tool to identify special cases of variation. 
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Table 1-1 Clinical Score Scale for Bovine Respiratory Disease Complex 
 
  
 
            
  Score Description   
  
0 Normal:  Nothing unusual in animal’s attitude and no abnormal 
respiratory symptoms present.    
  
1 Mild depression (somewhat slow coming to feed bunk, but did 
eat).  Mild respiratory symptoms present; serous nasal or ocular 
discharge and/or cough.   
  
2 Moderate depression (slight head/ears dropping, reluctant to move 
about, reluctant to come to the feed bunk).  Moderate respiratory 
distress:  Mucosus or mucopurulent nasal or ocular discharge 
and/or increase in respiratory rate or effort.   
  
3 Severe depression (pronounced head/ear droop’ very reluctant to 
move).  Severe respiratory distress: marked increase in respiratory 
rate or effort including: open mouth breathing, abdominal 
breathing, or extended head)   
  4 Moribund   
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 Abstract 
Objective – To evaluate the comparative efficacy of gamithromycin and tulathromycin for the 
control of undifferentiated bovine respiratory disease complex (BRDC) in high risk calves under 
field conditions. 
Animals – 2,529 calves. 
Procedures - The study was conducted in two feedlot operations (sites) located in Kansas and 
Nebraska.  Within each site, calves at high risk of developing BRDC were randomly assigned to 
two treatment groups: (1) Gamithromycin (n = 1,263) at 6.0 mg/kg s.c. and (2) Tulathromycin (n 
= 1,266) at 2.5 mg/kg s.c. Health outcomes (percentage morbidity, mortality, case fatality, and 
re-treatment) and animal performance (average daily gain [ADG], dry mater intake [DMI], and 
feed-to-gain [F:G]) were evaluated to determine the comparative efficacy of the antimicrobials.  
Results – Morbidity due to BRDC was higher (P = 0.03) among calves receiving gamithromycin 
(31.0 ±4.0%; mean estimate ± std err) compared with those receiving tulathromycin (22.9 
±3.9%); however, treatments were considered bioequivalent (P < 0.05) for BRDC mortality, case 
fatality rate and re-treatment rate within the limits of ±3.5%, ±10%, and ±16%, respectively.  
Final BW, ADG, DMI and F:G, were similar (P<0.05) between the groups of calves receiving 
gamithromycin and tulathromycin within the limits of ±37kg, ±0.1kg, ±0.3kg, and ±0.7, 
respectively.  
Conclusions and clinical relevance – BRDC morbidity rate was lower (P=0.03) in calves 
treated with tulathromycin compared with those treated with gamithromycin; nonetheless, 
treatments were considered bioequivalent for mortality rate, case fatality rate, re-treatment rate, 
and animal performance.  
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 Abbreviations 
ADG   Average daily gain 
BW   Body Weight 
BRDC   Bovine respiratory disease complex 
CI   Confidence Interval 
DMI   Dry matter intake 
F:G    Feed-to-gain ratio 
 
 Introduction 
Bovine Respiratory Disease Complex (BRDC) is the most common and expensive disease in 
feedlot cattle in the United States
1,2,3
. It accounts for approximately 50% of morbidity and over 
75% of mortality in feedyards
4
.  It has been estimated that BRDC causes annual economic losses 
of US$1 billion due to mortality, reduced performance, and treatment costs
2,5
.  The BRDC is a 
multifactorial syndrome caused by a combination of environmental factors, management 
practices, animal susceptibility, and viral and bacterial pathogens
5,6
. Preventive and control 
measures include management practices that enhance immune response, optimize nutrition, 
reduce animal stress, and minimize pathogen challenge
5,6
.  Methaphylaxis is one of the most 
effective control strategies for reduction of the negative effect of BRDC on health and 
performance
6
.  Metaphylaxis normally consists of mass administration of an approved 
antimicrobial product in a cattle population at high risk of developing BRDC
6
.  Tulathromycin is 
a relatively new subclass of antimicrobial macrolide (triamilide) labeled for metaphylactic use in 
cattle to control BRDC
3,7,8
.  Administration of tulathromycin at feedyard arrival to control BRDC 
in high risk calves has been shown to be effective to reduce morbidity and increase ADG when 
compared with saline control
6
.   Likewise, gamithromycin is a new antimicrobial azalide similar 
to macrolides that is approved for treatment and control of BRDC
3, 9, 10
.  Administration of 
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gamithromycin in a metaphylactic manner also reduces morbidity due to BRDC when compared 
with saline controls
10, 11
.  Both macrolides and azalides inhibit bacterial protein synthesis by 
binding 50s prokaryotic ribosomes
3,9
.  Macrolides are normally considered bacteriostatic; 
however, gamithromycin has been shown to have bactericidal activity against Mannheimia 
haemolytica, Pasteurella multocida, and Histophilus somni
3
. In field trials, tulathromycin has 
shown superior clinical efficacy vs. other macrolides, such as tilmicosin for the treatment of 
BRDC
7, 12.
  However, to our knowledge, no studies have been conducted to evaluate health 
outcomes and performance comparing gamythromycin vs. tulathromycin for the control of 
BRDC.  The objective of this study was to evaluate the comparative efficacy of gamithromycin 
and tulathromycin for the control of BRDC in high risk calves under field conditions. 
 Materials and methods  
 Animals 
A total of 2,529 crossbred calves purchased from auction markets located in Mississippi and 
northeast Oklahoma were enrolled in the study between October 2 and December 30, 2010. All 
procedures were approved by the Kansas State University Institutional Animal Care and Use 
Committee.  The study was conducted at two commercial feedlot operations that were willing to 
participate, and formal consent to conduct the research in the feedlot facilities was provided. 
Feedyards were located in Kansas (n = 1,002; mean body weight (BW), ±SD, 227 ±18kg) and 
Nebraska (n = 1,527; 235 ±41kg).  Animals were considered to be at high risk of developing 
undifferentiated BRDC.  Risk factors for developing BRDC in this cattle population included: 
light body weight (230 ±34 kg), stress and length of transportation (ranged from 10 to 16 hours), 
and level of commingling at the auction market, during the transportation process, and upon 
arrival. 
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 Processing 
Upon arrival, animals were placed into pens by date of arrival at the feedyard facility and 
processed within 24 hours of arrival.  Processing included giving an ear tag for individual 
identification, and recording of BW and rectal temperature. Intact bulls were castrated surgically.  
Calves were treated for internal and external parasites with fenbendazole
a
 and ivermectin
b
, and 
were vaccinated against clostridial pathogens
c
.  The location in Nebraska administered a viral 
respiratory vaccination against bovine herpesvirus-1, parainfluenza-3 and bovine respiratory 
syncytial virus
d
. The site in Kansas administered a multivalent vaccine containing viruses of 
bovine herpersvirus-1, parainfluenza-3, bovine respiratory syncytial virus, and bovine viral 
diarrhea (type I and type II)
e
 and an anabolic implant containing zeranol
f
.  
 Enrollment and treatment 
Animals were enrolled in the study only if they demonstrated no clinical signs of disease or 
injury as determined by the trial investigator at the time of post-arrival processing.  Exclusion 
criteria included injury, debilitation, any clinical signs of systemic diseases, or any known 
previous administration of antimicrobials prior to arrival.  
Animals that met the inclusion criteria were grouped in pairs based on order of appearance 
through the handling facility. Based on a randomization schedule previously developed for each 
site, animals within each pair were randomly allocated to receive either (1) Gamithromycin
g
 (6.0 
mg/kg, 2mL/50 kg, SQ, single-dose), or (2) Tulathromycin
h
 (2.5 mg/kg, 1.25mL/50 kg, SQ, 
single-dose).  Animal BW obtained at processing was used for dose determination. Treatments 
were administered subcutaneously in the same side of the neck in front of the shoulder, with a 
maximum volume of 10 mL per injection site.  Treatments were administered by the investigator 
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at the time of processing. Incidence of castrated bulls did not significantly differ (P = 0.33) 
between the calves receiving tulathromycin (3.6%) and those receiving gamithromycin (3.3%). 
From day 0 to day 120 post-enrollment, general health evaluations were conducted in the pens 
through routine feedlot health procedures performed by qualified animal health care personnel 
who were not present during the treatment administration (blinded). Morbid animals were 
examined and diagnosed as having BRDC or other (gastrointestinal, musculoskeletal, etc.) 
infirmities.  Animals which were categorized as morbid due to BRDC were defined as animals 
showing clinical scores of 1, 2 or 3 according to the clinical score scale (Appendix A) and having 
rectal temperature equal or greater than 40 ºC. Sick animals received concurrent medications 
according to the standard feedyard procedures and returned to their study pens.  In both sites, 
animals diagnosed with BRDC received a single dose of florfenicol
i
 (40mg/kg BW, 6mL/45 kg, 
SQ) as a first treatment, and a single dose of enrofloxacin
j
 (7.5-12.5mg/kg BW, 3.75-
6.25mL/50kg, SQ) as a second treatment (re-treatment). Animals that received a third treatment 
during the 120 day period received Ceftiofur
k
 (6.6 mg/kg BW, 1.5mL/45 kg, SQ base-of-the-ear) 
in Kansas and Oxytetracycline
l
 (20mg/kg BW, 1mL/10kg, IM) in Nebraska. Moribund animals 
were humanely euthanized according to the guidelines of the Animal Welfare Committee of the 
American Association of the Bovine Practitioners
13
. Necropsy was performed by qualified 
personnel for animals that either died or were euthanized. Mortality attributed to BRDC was 
confirmed by presence of bronchopneumonia. Mortalities not associated with BRDC were not 
included in the analysis of BRDC mortality or case fatality rate. 
For the analysis of animal performance, dry matter intake (DMI) and days on feed (DOF) were 
obtained during the entire feeding period. Individual animal BW was obtained at time of 
processing (arrival), and final BW was calculated based on the pen weight at time of harvest.  
34 
 
For the calculations on a deads-in basis, pen ADG was calculated by subtracting initial BW from 
final BW and divided by days on feed (DOF), and feed to gain (F:G) was calculated by dividing 
DMI by ADG.  For the analysis of performance on a deads-out basis, animals that died due to 
BRDC during the first 120 DOF were excluded from the calculations of final BW, ADG and 
F:G. 
 Housing  
Animals were housed in open air group pens. Average number of animals per pen was 50 in 
Kansas and 110 in Nebraska. Animals were fed with a ration formulated to meet or exceed the 
requirements of the National Research Council for maintenance and expected growth
14
.  All 
animals had ad libitum access to water. 
 Statistical Analysis 
Continuous responses, namely initial BW, rectal temperature at enrollment, final BW, ADG, 
DMI, and F:G were modeled using general linear mixed models.  For all responses, the linear 
predictor included the fixed effect of treatment at arrival (e.i. gamithromycin or tulathromycin). 
Random effect specification was fine-tuned to each response to accommodate the experimental 
design structure while including only random effects with non-zero estimates of variance 
components. In all cases, the random effect of the combination of treatment and site was 
assessed but dropped from the models based on a variance component converged to zero. 
For initial BW and for animal performance outcomes (i.e. final BW, ADG, DMI, and F:G), the 
random effect of arrival date was modeled as a blocking factor. For rectal temperature, the 
random effects of arrival date and its crossproduct with treatment was specified. Initial weight 
and total days on feed were used as covariates in the statistical models for rectal temperature and 
animal performance outcomes, respectively.  
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Generalized linear mixed models were fitted to categorical binary responses using a logit link 
function and assuming a Bernoulli distribution.  For mortality, morbidity, and re-treatment, the 
linear predictor in the model included the fixed effects of treatment and rectal temperature status 
at arrival (Normal: < 40 ºC, or Fever: ≥ 40 ºC) and initial weight at arrival as a covariate; in turn, 
the random effect for the combination of arrival date and treatment was used to recognize the 
experimental unit for treatment. For modeling re-treatment, the covariate initial weight at arrival 
was removed due to a non-significant (P > 0.05) contribution to the model.  For case fatality rate, 
the linear predictor in the model included treatment as a fixed effect and the combination of 
arrival date × treatment as a random effect to recognize the appropriate experimental unit for 
treatment.  
Parameter estimates from the statistical models described above were used to conduct both 
classical and bioequivalence hypothesis testing. On a classical testing framework, treatments 
were considered to yield significantly different outcomes based on P-values < 0.05 on the 
corresponding ANOVA Type III F-test statistics; marginal evidence for treatment differences 
were declared at P < 0.10. In turn, 90% confidence intervals (CL) on treatment differences were 
constructed for each response to assess evidence for equivalent treatment performance
16
.  If a 
90% CI on the treatment difference fell within appropriate upper and lower equivalence limits set 
for a given response, then average bioequivalence (P < 0.05) between treatments for that 
response can be concluded
16
. 
All statistical models were fitted using a statistical analysis software
m
. Kenward-Roger’s 
approximation was used to estimate degrees of freedom and to make the corresponding 
adjustments in estimation of standard errors. Pairwise comparisons were conducted using either 
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Tukey-Kramer or Bonferroni's method to adjust for multiple comparisons and prevent inflation 
of Type I error. 
 Results 
No clinical adverse reactions were observed after treatment administration, and no animals were 
removed from the study before day 120.  As expected, no evidence of differences between 
treatments was found for initial BW (P ≥ 0.97) or rectal temperature (P ≥ 0.72) at enrollment 
(table 2.1).  Likewise, the proportion of animals that had fever at arrival did not differ (P = 0.87) 
between treatment groups (19.3% for both: gamithromycin and tulathromycin); thus indicating 
no evidence for concerns with the randomization approach. 
The estimated overall morbidity rate (BRDC incidence) during the first 120 DOF was 31.0±4.0% 
(mean estimate ± std err). Meanwhile, differences between treatments were apparent (P = 0.03); 
animals that received gamithromycin had higher morbidity rate (31.0±4%) compared with those 
that received tulathromycin (22.9± 4%; Table 2.1).  Regardless treatment, and given an average 
initial BW of 230 kg, the estimated odds of being treated (first treatment) for BRDC during the 
first 120 DOF were 1.78 times greater (95% CI = [1.3, 2.45]) for animals that had fever at arrival 
compared with those that had normal rectal temperature at arrival. For the covariate initial BW at 
arrival,  the estimated odds ratio for being treated for BRDC (first treatment during the first 120 
DOF) for a 50kg decrease in initial BW relative to the average arrival weight of 230kg was 1.41 
(95% CI = [1.22, 1.63]).  This odds ratio estimate indicates that there is a greater risk of being 
treated for BRDC during the first 120 DOF in lighter animals at arrival.  
During the first 120 DOF, the estimated overall mortality rate averaged 3.84±1.0% (mean 
estimate ± std err). Estimated mortality rate for tulathromycin was 3.5±1.3% and for 
gamithromycin was 4.2±1.7%.  Bioequivalence between treatments was established for mortality 
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rate due to BRDC within the limits of ±3.5%.  The estimated overall case fatality rate averaged 
15.9±3.1%.  Case fatality rate averaged 19.5±3.9% for animals that received tulathromycin, and 
averaged 14.8±3.8% for animals that received gamithromycin. Then, treatment bioequivalence 
(P < 0.05) was established between gamithromycin and tulathromycin for BRDC case fatality 
rate within the limits of ±16%.  Overall re-treatment rate (second treatment) averaged 40.1±2.6% 
across treatment groups. Re-treatment rate for gamithromycin was 41.5±4.18%, and re-treatment 
rate for tulathromycin was 39.6±3.4%.  Treatments bioequivalence (P < 0.05) was established 
between gamithromycin and tulathromycin for BRDC re-treatment rate within the limits of 
±10% (Table 2.2). 
Regardless of treatment and given an average arrival weight of 230kg, the odds of mortality due 
to BRDC during the first 120 DOF were estimated to be approximately 1.5 times greater (95% 
CI = [1.045, 2.130]) for animal that had fever at arrival compared with those that had normal 
temperature at arrival, yielding an odds ratio of 1.49.  After adjusting for temperature at arrival 
and regardless of treatment, the estimated odds ratio for mortality due to BRDC during the first 
120 days for a 50kg decrease in initial BW relative to the average arrival weight of 230kg was 
1.29 (95% CI = [1.06, 1.43]).  The odds ratio estimate indicates that there is a greater risk of 
mortality due to BRDC during the first 120 DOF in animals that are lighter at arrival.   
For the analysis of animal performance on a deads-in basis, final BW at harvest was 
bioequivalent (P < 0.05) between gamithromycin and tulathromycin within the limits of ±37kg. 
Also, bioequivalence between treatments (P < 0.05) was established for ADG within the limits of 
±0.01kg. For F:G, bioequivalence (P<0.05) was established between animals that received 
tulathromycin or those that received gamithromycin within the limits of ±0.7 (table 2.3).  
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For animal performance on a deads-out basis, final BW was considered bioequivalent (P<0.05) 
between animals that received tulathromycin and those that received gamithromycin within the 
limits of ±9.5kg. Also, bioequivalence (P<0.05) was established for ADG between tulathromycin 
and gamithromycin within the limits of ±0.1kg.   Finally, bioequivalence (P<0.05) was 
established for F:G between animals that received tulathromycin and those that receive 
gamithromycin within the limits of ±0.6 (table 2.4). 
 Discussion 
Gamithromycin and tulathromycin have shown to be efficacious antimicrobials for the control of 
bovine respiratory disease when they are used in high risk calves according to the label dose
7, 12
. 
To our knowledge, this is the first experiment that compares gamithromycin vs. tulathromycin to 
control BRDC in high risk feedlot cattle.  
Previous studies conducted to evaluate antimicrobials for the control of BRDC used a period of 
10 days
10
, 14 days
7,11
, or 28 days
16
 after enrollment to evaluate health outcomes; however, in the 
present study, we were interested in evaluating health outcomes over a longer period of time; 
therefore, a total length of 120 DOF was used to evaluate health outcomes.  It is important to 
mention that 95% of the total cumulative mortality, for both gamithromycin and tulathromycin, 
occurred during the first 42 DOF (table 2.5); and 95% of the total cumulative morbidity occurred 
during the first 70 DOF (table 2.6). An evaluation over a period of 70 DOF (e.g. 10 weeks) will 
provide enough information about health performance in in high risk calves after metaphylactic 
administration of injectable antimicrobials. 
In the present study, rectal temperature status at processing was monitored to control for animals 
experiencing fever at arrival and evaluate the effect of the treatment in animals with fever and 
those with normal temperature. There was no evidence of differences in the proportion of 
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animals with fever at arrival between treatments groups (P=0. 87); the proportion of animals 
with fever in both groups averaged 19.3% ; also, the interaction of treatment × rectal temperature 
status was not significant (P≥0.69) in the statistical models for morbidity, mortality, case fatality 
rate, and re-treatment rate. Therefore, the effect of treatment was the same in all levels of rectal 
temperature status: fever and normal temperature.  
In the present study, the statistical model for mortality and morbidity included the covariate of 
initial BW, so we were able to account for the effect of body weight at arrival. The interaction of 
IBW × treatment was also evaluated; however, it was not significant (P≥0.69) in fitting the 
models for mortality or morbidity. Interestingly, this finding showed that the main effect of 
metaphylactic treatment did not interact with initial BW. It is important to mention that initial 
BW, used as a covariate in the models for mortality and morbidity, contributed significantly (P < 
0.01) to the fit of the models; therefore, the analysis of odds ratios for initial BW showed that 
lighter animals were at greater risk for treatment or death due to BRDC.  This finding agrees 
with the data reported in previous studies that have showed that body weight is associated with 
the development of BRDC
15
.   
Even though classical hypothesis testing was conducted for all outcomes, the bioequivalence 
hypothesis test was used for those outcomes where no evidence of differences was found (P > 
0.05). With the classical hypothesis testing, a null hypothesis of no treatment mean differences 
can either be rejected or failed to be rejected, but it cannot be accepted
19
.  That is, one cannot 
conclude on "no treatment differences" using the classical hypothesis testing approach because 
failure to reject the classical null hypothesis can be attributable to either no actual differences 
between group means
19
,
 
or simply a lack of statistical power in the experimental design. Thus, 
failure to reject a null hypothesis provides only indecisive results on the comparison of treatment 
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means. In order to assess the anticipated similarity of treatment performance (as opposed to 
differential treatment effects), we conducted bioequivalence hypothesis testing
19
. Using this 
approach, veterinarians and animal health personnel can expect that both antimicrobials will 
yield a similar outcome (P<0.05) within a difference established with the 95% confidence limits. 
Consequently, we established bioequivalence (P < 0.05) between antimicrobials within the limits 
for mortality, case fatality rate and performance (final BW, ADG, DMI, and F:G).  
For the analysis of animal performance, both antimicrobials were considered bioequivalent (P < 
0.05) for final BW, ADG, DMI and F:G (deads-in and deads-out basis).  In a previous study 
comparing two macrolides, namely tulathromycin and tilmicosin
n
, no evidence of differences (P 
> 0.05) were found in ADG between those antimicrobials given at arrival for control of BRDC in 
high risk calves
16
.  However, no bioequivalence tests were conducted in that study. 
It should be noted that mortality rates in the present study were much higher (overall mortality 
rate averaged 3.8±1.0%, mean estimate, ± SEM) compared with those reported in previous 
studies (overall mortality rate = 0%)
10,11
.  This suggests that calves enrolled in the current study 
may have been at higher risk to develop BRDC at arrival compared with calves in previous 
studies. Risk factors for BRDC in the present study included: stress due to transportation which 
ranged from 10 to 16 hours, and light body weight at arrival (230 ±18 kg). In addition, calves 
were acquired from auction markets, and were commingled with unfamiliar animals at the 
auction market, during transportation, and at arrival to the feedlot.  Furthermore, enrollment 
occurred during the fall and early winter; this time of the year also has been proposed a 
predisposing factor for developing BRDC
20
.   
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Since the study did not include a negative control group, we were unable to determine the 
efficacy of metaphylaxis compared with placebo in terms of mortality, morbidity, re-treatment 
rate, and case fatality rate. 
In the present study, morbidity rates were higher (P ≤ 0.03) for animals receiving gamithromycin 
compared with those receiving tulathromycin, 31.0% and 22.9% respectively.  This health 
outcome was the only one that was different between treatments (P < 0.05); nonetheless, it could 
be argued that evaluation of morbid animals is based on clinical observations of BRDC 
symptoms that combine subjective and objective evaluations.  According to White et al., 
sensitivity and specificity of clinical diagnosis of BRDC under field situations is very low (61.8 
and 62.8% respectively)
21
 due to a high degree of diagnostic error. Further investigation with 
high sensitivity and specificity diagnosis technologies will allow us to perform more accurate 
evaluations of morbidity rates in field trials. 
 Conclusion 
Under commercial feedlot conditions, the comparative efficacy of the administration of 
gamithromycin or tulathromycin to control BRDC was similar in mortality rate, case fatality rate, 
re-treatment rate, and animal performance (DMI, F:G, ADG), so both antimicrobials were 
considered bioequivalent.  Nevertheless, animals treated with gamithromycin had greater 
morbidity rates (BRDC incidence) compared with tulathromycin.  
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 Footnotes 
a
 SafeGuard, Intervet/Schering-Plough Animal Health, Millsboro, DE. 
b 
Ivomec Plus, Merial LTD, Duluth, GA. 
c
 Vision 7/Somnus, Intervet/Schering-Plough Animal Health, Millsboro, DE 
d
 Bovishield Gold 5, Pfizer Animal Health, New York, NY.  
e
 Inforce 3, Pfizer Animal Health, New York, NY  
f
 Ralgro, Intervet/Schering-Plough Animal Health, Millsboro, DE. 
g
 Zactran, Merial LTD, Duluth, GA. 
h
 Draxxin, Pfizer Animal Health, New York, NY. 
i
 Nuflor, Intervet/Schering-Plough Animal Health, Millsboro, DE 
j
 Baytril, Bayer Animal Health, Shawnee Mission, KS 
k
 Excede, Pfizer Animal Health, New York, NY. 
l
 Bio-Mycin, Boehringer Ingelheim Vetmedica, St. Joseph, MO. 
m
 PROC GLIMMIX, SAS, version 9.3, SAS Institute, Cary, NC 
n
 Micotil, Eli Lilly and Company, Indianapolis, IN. 
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 Tables 
 
Table 2-1 Least square means estimates (and estimated standard errors of the means) for 
initial BW and rectal temperature at arrival, and morbidity rate due to BRDC during 120 
days on feed for high risk calves receiving tulathromycin or gamithromycin at arrival 
 
                
  
      
  
  ITEM Tulathromycin SEM Gamithromycin SEM P-value   
  Rectal temperature (°C) 39.3 0.1 39.3 0.1 0.72   
  Initial BW
1
 (kg) 228.0 5.6 227.9 5.6 0.97   
 BRDC Morbidity
2
 (%) 22.9 3.9 31.0 3.8 0.03  
        
 
1 
Animal BW at time of processing (arrival) 
2
 BRDC morbidity incidence (first treatment)  
        
        
        
Table 2-2 Least square means estimates (and estimated standard errors of the means) and 
bioequivalence limits for mortality, re-treatment, and case fatality rate due to BRDC 
during 120 days on feed in calves receiving tulathromycin or gamithromycin at arrival 
        
        
        
      Bioequivalence  
 ITEM Tulathromycin SEM Gamithromycin SEM Limits
3
  
 BRDC Mortality (%) 3.5 1.3 4.2 1.7   3.5  
 Re-treatment
4
 (%) 39.5 3.4 41.5 4.2 10.0  
 Case fatality rate (%) 19.5 3.9 14.8 3.8 16.0  
        
  
3
 Average bioequivalence between treatments (P<0.05) established within the ±limits 
4 
BRDC re-treatment rate (second treatment)   
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Table 2-3 Least square means estimates (and estimated standard errors of the means) and 
bioequivalence limits for final BW, ADG, DMI, and F:G (from the entire feeding period) 
for calves receiving tulathromycin or gamithromycin at arrival. Analysis on a deads-in 
basis 
 
        
     
      Bioequivalence  
 ITEM Tulathromycin SEM Gamithromycin SEM Limits
1
  
 Final BW, kg 495.0 11.7 486.0 11.5 37.0  
 ADG, kg/day 1.1 0.03 1.0 0.03 0.1  
 DMI, kg/day 7.4 0.08 7.3 0.08 0.3  
 F:G  ratio 6.6 0.18 6.8 0.18 0.7  
        
 
1
 Average bioequivalence between treatments (P<0.05) established within the ±limits  
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Table 2-4 Least square means estimates (and estimated standard errors of the means) and 
bioequivalence limits for final BW, ADG, DMI, and F:G (from the entire feeding period) 
for calves receiving tulathromycin or gamithromycin at arrival, analysis on a deads-out 
basis 
 
        
        
      Bioequivalence  
 ITEM Tulathromycin SEM Gamithromycin SEM Limits
1
  
 Final BW, kg 530.1 6.3 529.5 6.3 9.5  
 ADG, kg/day   1.2 0.01 1.2 0.01 0.1  
 F:G  ratio 6.5 0.14 6.6 0.27 0.6  
        
  
1
 Average bioequivalence between treatments (P<0.05) established within the ± limits    
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Table 2-5 Number of animals that died due to BRDC (Case fatality rate) within the first 
120 days post-enrollment that were treated with tulathromycin or gamithromycin, across 
all sites 
              
  
     
  
  Days on Feed Gamithromycin Tulathromycin Total Cumulative %   
  7 15 3 18 10   
  14 28 29 57 43   
  21 12 8 20 55   
  28 20 14 34 74   
  35 15 14 29 91   
  42 2 6 8 95   
  49 1 1 2 97   
  56 0 1 1 97   
  63 1 1 2 98   
  77 1 1 2 99   
  98 0 1 1 100   
  120 0 0 0 100   
  TOTAL 95 79 174 100   
  
     
  
  Cumulative BRDC mortality rate (%) from total (gamithromycin and tulathromycin) 
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Table 2-6 Number of animals that were morbid (BRDC incidence) within the first 120 days 
post-enrollment, across all sites. 
              
  Days on Feed Gamithromycin Tulathromycin Total Cumulative %   
  7 68 39 107 16   
  14 139 99 238 51   
  21 62 43 105 67   
  28 39 37 76 78   
  35 24 25 49 85   
  42 15 15 30 89   
  49 8 5 13 91   
  56 4 5 9 93   
  63 2 6 8 94   
  70 3 1 4 95   
  77 1 2 3 95   
  84 4 3 7 96   
  91 0 4 4 97   
  98 2 3 5 97   
  105 2 2 4 98   
  112 4 3 7 99   
  120 1 6 7 100   
  TOTAL 378 298 676 100   
  
     
  
  Cumulative BRDC morbidity rate (%) from total (gamithromycin and tulathromycin)   
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Chapter 3 - Comparative efficacy of gamithromycin and 
tulathromycin for the treatment of undifferentiated bovine 
respiratory disease complex in high risk calves under field 
conditions 
Siddartha Torres, MVZ; Dan U. Thomson, DVM, PhD; Nora M. Bello, DVM, PhD; Bruce 
Nosky, DVM; Chris D. Reinhardt, PhD 
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State University, Manhattan, KS 66506; Large Animal Veterinary Services (Nosky), Merial 
Limited, Duluth, GA 30096; and the Department of Animal Sciences and Industry (Reinhardt), 
College of Agriculture, Kansas State University, Manhattan, KS 66506. 
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 Abstract 
 
Objective – To evaluate the clinical efficacy of gamithromycin and tulathromycin for the 
treatment of undifferentiated bovine respiratory disease complex (BRDC) in feedlot calves under 
field conditions. 
Animals – 1,049 calves allocated in six feedlot operations (sites). 
Procedures –Newly arrived feedlot calves diagnosed with BRDC were randomly assigned to 
two treatment groups: (1) Gamithromycin (n = 523) and (2) Tulathromycin (n = 526).  Fatality 
rate, re-treatment rate, average daily gain (ADG), and body weight during 120 days post-
enrolment were evaluated to determine the comparative efficacy of the antimicrobials. In 
addition, two sites evaluated clinical scores during 10 days after treatment to determine 
comparative recovery rates. 
Results – During the 120 days post-enrollment period, re-treatment rate was higher among 
animals treated with gamithromycin (estimated mean±SEM; 17.7± 7%) compared with those 
treated with tulathromycin (9.0±4%). Treatments were bioequivalent (P < 0.05) for case fatality 
rate, and performance (final BW and ADG). Clinical scores during 10 days post-treatment were 
not significantly different (P = 0.97) between treatments. 
Conclusions and clinical relevance – In the present study, gamithromycin and tulathromycin 
yield similar BRDC case fatality rate, ADG and final BW during the first 120 days post-
treatment. Nevertheless, tulathromycin had lower re-treatment rates compared with 
gamithromycin.  
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 Abbreviations 
ADG  Average daily gain 
BW  Body Weight 
BRDC Bovine respiratory disease complex 
CI  Confidence interval 
SD  Standard Deviation 
SEM  Standard Error of the Mean 
 Introduction 
Bovine Respiratory Disease Complex is the most costly and common disease in feedlot cattle in 
North America
1-3
. Approximately 50% of total feedlot morbidity and 75% of death loss is 
considered to be due to BRDC
2
.  Annual economic losses are estimated at US$1 billion due to 
mortality, treatment costs, and reduction in performance, and carcass value
4
 
5, 6
. Bovine 
respiratory disease complex is a multifactorial syndrome caused by environmental factors, 
management practices, animal susceptibility, and viral and bacterial pathogens
6
. Single dose 
injectable antimicrobials have shown efficacy to treat animals diagnosed with BRDC
7-12
.  
Among injectable antimicrobials, tulathromycin is a relatively new macrolide that has shown 
superior clinical efficacy vs. other single dose macrolides, such as tilmicosin for the treatment of 
the BRDC
7, 11, 12
. Gamithromycin is a new Azalide antimicrobial similar to macrolides that is 
labeled for the treatment of BRDC
10, 13
.  Both antimicrobials, tulathomycin and gamithromycin, 
inhibit bacterial protein synthesis by binding 50s prokaryotic ribosomes
13
.  Macrolides are 
normally considered bacteriostatic; however, Gamithromycin has shown to have bactericidal 
activity against M. haemolytica, P. multocida, and H. somni 
13, 14
.  To our knowledge, no 
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comparative studies have been conducted to evaluate the comparative clinical efficacy of these 
antimicrobials for the treatment of BRDC.  The objective of this field study was to evaluate the 
comparative efficacy of gamithromycin and tulathromycin for the treatment of BRDC in beef 
calves under commercial feedlot conditions. 
 Materials and Methods 
 Animals 
A total of 1,049 crossbred calves acquired from auction markets across the United States were 
enrolled in the study between October and Dec of 2010.  
 All procedures were approved by the Kansas State University Institutional Animal Care and use 
Committee.  This multi-site field study was conducted in six different commercial feedlot 
facilities (sites) that were willing to participate, and owners provided a formal consent to conduct 
the research in the feedlot facilities.  Feedlots were located in Colorado (n=100; mean body 
weight (BW) ± Standard Deviation (SD); 220 ± 22 kg), Idaho (n = 200; 244 ± 25 kg), Kansas (n 
= 216; 227 ± 21 kg), Nebraska (n = 196, 244 ± 28 kg), Oklahoma (n = 112; 236 ± 21 kg), and 
Texas (n = 225; 244 ± 18 kg). Enrollment occurred between December 10
th
 and December 12
th
 in 
Colorado, November 6
th
 and November 17
th
 in Idaho, October 25
th
 and November 1
st
 in Kansas, 
December 6
th
 and December 30
th
 in Oklahoma, and November 7
th
 and November 18
th
 in Texas. 
 Processing 
Upon arrival, animals were placed into pens by date of arrival at the feedyard and processed 
within 24 hours of arrival.  Processing included giving an ear tag for individual identification, 
recording of BW, and intact bulls were castrated surgically. Calves were dewormed with 
ivermectin
a
 or doramectin
b
 (Idaho) and vaccinated against clostridial pathogens in Kansas
c
, 
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Idaho
d
, Oklahoma
e
, and Texas
f
. A multivalent vaccine containing antigens against bovine 
herpersvirus-1, parainfluenza-3, bovine respiratory syncytial virus, and bovine viral diarrhea type 
I and type II was administered in Kansas
g
, Nebraska
h
, Colorado
i
, Idaho
i
, and Oklahoma
j
.  In 
Texas, viral vaccination included antigens against bovine herpesvirus-1 and bovine viral diarrhea 
type I and type II
k
. In addition, an anabolic implant containing trenbolone acetate and estradiol 
was administered in Kansas
l
, Idaho
m
, and Texas
n
 at the time of processing. No antimicrobials 
were administered at arrival. 
 Enrollment and treatment 
After processing, animals were placed in their home pens and observed daily by qualified animal 
health care personnel to determine health status. Animals enrolled in the study included calves 
showing respiratory clinical scores of 1 or 2 and having rectal temperature ≥ 40ºC, or animals 
showing clinical scores of 3 regardless rectal temperatures (Appendix A). Animals that were 
injured, debilitated, or suffering from systemic diseases (gastrointestinal, musculoskeletal, etc.) 
other than BRDC were not included in the study. Body weight was obtained at the time of 
enrollment for dose determination and measurements of performance.  
Animals that met the inclusion criteria were grouped in pairs based on order of appearance 
through the handling facility.   Within each pair group, animals were assigned to treatment by a 
previously determined randomization schedule unique for each site, receiving either (1) 
Gamithromycin
o
 (6.0 mg/kg, 2mL/50 kg, S.C., single-dose), or (2) Tulathromycin
p
 (2.5 mg/kg, 
1.25 mL/50 kg, S.C., single-dose).  Treatments were administered subcutaneously in the same 
side of the neck in front of the shoulder, with a maximum volume of 10 mL per injection site. 
Treatments were administered by the investigator. No evidence of differences in castrated bulls 
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incidence across treatments (P = 0.61).  All animals were observed for adverse experiences after 
treatment.   
Enrolled animals in Colorado and Oklahoma were housed in a single hospital pen (both 
treatments combined within each site) and were observed daily (during 10 days port-treatment) 
by trained animal health care professionals who were blinded to treatment. Individual animal 
observations, based on clinical score scale (Appendix A), were recorded for each calf for the day 
of treatment and for 10 days post-treatment for further analysis. From day 0 through day 120 
post-enrollment, general health evaluations were conducted within the home pens through 
routine feedlot health procedures performed by qualified animal health care personnel who were 
not present during the treatment administration (blinded). Morbid animals were examined and 
diagnosed as having BRDC or other disorders (gastrointestinal, musculoskeletal, etc.), and 
received concurrent medications common to both experimental treatment groups within each site 
according to the standard feedyard procedures and returned to their study pens.  Animal health 
records were kept in order to analyze data pertaining to the numbers of animals that were treated 
for BRDC or died due to BRDC within the first 120 days post-enrollment. Necropsy was 
performed by qualified personnel for animals that either died or were euthanized. If necessary, 
humane euthanasia was performed according to the guidelines of the Animal Welfare Committee 
of the American Association of the Bovine Practitioners
15
.   Mortalities not associated with 
BRDC were not included in the analysis of BRDC fatality rates. 
 Housing   
Animals were housed in open air group pens. Animals were fed with a ration typical of the 
feedlot region and formulated to meet or exceed the requirements of the National Research 
Council
16
 for maintenance and expected growth.  All animals had ad libitum access to water. 
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Individual BW was obtained at time of enrollment and at day 120 (Colorado, Idaho, Nebraska 
and Oklahoma), day 170 (Texas) and day 180 (Kansas) to obtain ADG for each animal.  
Nevertheless, health was monitored continuously through day 120 at all sites.  Average daily 
gain was calculated by subtracting initial BW from final BW and divided by DOF. Case fatality 
rate represents the number of calves that died due to BRDC during the first 120 DOF divided by 
number of calves enrolled in each treatment group; mortalities attributed to BRDC was 
confirmed by presence of bronchopneumonia at necropsy. Re-treatment rate represents the 
number of calves that required a second treatment for BRDC during the first 120 DOF divided 
by the number of calves initially enrolled.   
 Statistical Analysis 
General linear mixed models were fitted for continuous responses (i.e. initial body weight, rectal 
temperature at enrollment, final BW, and ADG). The linear predictor in the model for initial BW 
and rectal temperature at enrollment included treatment as a fixed effect; enrollment-date and 
site were included as random effects. The combination of treatment × site was assessed but 
dropped from the models based on a variance component estimated at zero boundary. For final 
BW and ADG, the linear predictor in the model included treatment as a fixed effect, and the 
random effects of site and the combination of site × treatment was used as a random effect to 
recognize the experimental unit for treatment. Initial BW at arrival and days-on-feed were 
included as covariates for the analysis of final BW and ADG; however, the covariate days-on-
feed was removed from analysis of ADG due to non-significant (P > 0.05) contribution to the 
model.  
Generalized linear mixed models were fitted to categorical binary responses (i.e. case fatality 
rate and re-treatment rate) using a logit link function. The linear predictor in the model included 
57 
 
treatment as a fixed effect, and site as a random effect; the combination of treatment × site was 
assessed but dropped from the models based on a variance component estimated at zero 
boundary. Rectal temperature at enrollment and initial BW were used as covariates; however, the 
covariate rectal temperature at enrollment was removed from the analysis of case fatality rate 
based due to non-significant (P > 0.05) contribution to the model.  
Clinical scores were analyzed using generalized linear mixed model assuming a categorical 
multinomial distribution of the response modeled with a cumulative logit link function. The 
linear predictor for the statistical model included the fixed effects of antimicrobial treatment, 
time point of evaluation (0 and daily until 10 days after treatment), and their 2-way interaction. 
The random effect of site combined with arrival date was fitted in the linear predictor as a 
blocking factor for antimicrobial treatment. In addition, a random effect of animal nested within 
treatment in each site-by-arrival date combination was also incorporated into the model to 
recognize the experimental unit for treatment and repeated measures over time for each animal.   
Parameter estimates from the statistical models described above were used to conduct both 
classical and bioequivalence hypothesis testing. On a classical testing framework, treatments 
were considered to yield significantly different outcomes based on P-values < 0.05 on the 
corresponding ANOVA Type III F-test statistics; marginal evidence for treatment differences 
were declared at P < 0.10. In turn, 90% confidence intervals (CI) on treatment differences were 
constructed for each response to assess evidence for equivalent treatment performance
18
. If a 
90% CI on the treatment difference fell within appropriate upper and lower equivalence limits set 
for a given response, average bioequivalence between treatments for that response can be 
concluded with P < 0.05
18
.  
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All statistical models were fitted using a statistical analysis software
q
. Kenward-Roger’s 
approximation was used to estimate degrees of freedom and to make the corresponding 
adjustments in estimation of standard errors. Pairwise comparisons were conducted using either 
Tukey-Kramer or Bonferroni's method to adjust for multiple comparisons and prevent inflation 
of Type I error. 
 Results 
No clinical adverse reactions were observed after treatment administration, and no animals were 
removed from the study before day 120 post-treatment. Within each site, animals arrived to the 
feedlot facility within a period of 1 day (Colorado and Kansas), 6 days (Nebraska), 8 days (Idaho 
and Oklahoma), and 10 days (Texas). At enrollment, no evidence of differences (P = 0.38) were 
found in initial body weight among calves receiving gamithromycin (235±1.6kg) and those 
receiving tulathromycin (236±1.6kg). Likewise, no evidence of differences for rectal temperature 
at enrollment (P = 0.64) were found comparing calves receiving gamithromycin (40.2±0.06ºC) 
and those receiving tulathromycin (40.2±0.06ºC). Moreover, the proportion of animals with fever 
(rectal temperature ≥ 40ºC) at enrolment was not significantly different (P = 0.11) between 
gamithromycin (64.5±5%) and tulatrhomycin (60.4±6%, Table 3.1). Across treatment groups, 
enrollment (initial treatment for BRDC) was administered at 3.6±0.7days after cattle arrived to 
the feedyard (for both treatment groups), and no evidence of differences were found in DOF for 
the first treatment (P=0.52) between treatment groups. Animals receiving gamithromycin were 
enrolled in average at 3.6±0.7 days after arrival, and those treated with tulathromycin were 
enrolled in average at 3.7±0.7 days after arrival (Table 3.1).  
Overall re-treatment rate (second treatment) due to BRDC averaged 12.8±5% (estimated 
mean±SEM) across treatment groups. Re-treatment rate was greater (P < 0.01) in calves treated 
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with gamithromycin (17.7± 7%) compared with those treated with tulathromycin (9.0±4%, Table 
3.1).  Interestingly, the covariate initial BW at enrolment yield a significant contribution to fit the 
model for re-treatment rate (P<0.04); then, controlling for treatment, the estimated odds ratio for 
re-treatment for a 50kg reduction in initial BW relative to the average arrival weight of 233kg 
was 1.55 (95% CI = [1.01, 2.39]); hence, animals with lower initial BW had greater risk of re-
treatment for BRDC during the first 120 DOF, same for both treatments. Likewise, the covariate 
rectal temperature yield a significant contribution to fit the model for re-treatment rate (P≤0.01).  
The estimated odds ratios for re-treatment rate was 1.8 (95% CI = [1.4, 2.3]) times greater for an 
increment of 1°C relative to a 39.9°C; the same odds ratio both treatment groups. Therefore, 
animals with greater rectal temperature were at higher risk of being re-treated during the first 120 
DOF.  Overall estimated case fatality rate due to BRDC averaged 4.1±2.4% across treatment 
groups. For calves treated with tulathromycin, case fatality rate was 3.7±2%, and for  calves 
treated with gamithromycin, case fatality rate averaged 4.2±2%; consequently, both treatment 
were considered bioequivalent at ±2.0% of case fatality rate (P < 0.05, Table 3.2).  
Tulathromycin was used as a reference category for estimation of the 90% CI on the mean 
treatment difference in the bioequivalence test. Interestingly, the covariate rectal temperature 
yield a significant contribution to fit the model of case fatality rate (P<0.01). Then, the estimated 
odds ratio for mortality due to BRDC for an increment of 1ºC in rectal temperature relative to a 
rectal temperature of 39.9ºC was 1.94 (95% CI = [1.51, 2.48]); therefore, the odds of died due to 
BRDC was 1.9 times greater in animals with fever (rectal temperature ≥ 40.0 ºC) compared with 
those with normal rectal temperature.  
For the analysis of performance (i.e. final body weight and average daily gain), no evidences of 
differences was found between treatment groups. Therefore, bioequivalence tests were conducted 
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for performance outcomes. For final body eight, bioequivalence (P < 0.05) was established for 
final BW between gamithromycin (450, ±7.0kg) and tulathromycin (456, ±7.0kg) within the 
limits of ±7kg. Likewise, ADG was considered bioequivalent (P<0.05) between animals that 
received tulathromycin (1.57, ±0.06kg) and gamithromycin (1.52, ±0.06kg) within the limits of 
±0.09kg (Table 3.2). 
For the analysis of clinical scores during 10 days after treatment administration, only performed 
in the feedlots located in Cololado and Oklahoma, no evidence of treatment effect on clinical 
scores were found (P=0.97).  In addition, regardless of antimicrobial treatment, clinical scores 
changed over time (P<0.01), whereby lower scores became more frequent during the 10 day long 
evaluation period.  
 Discussion 
Both Gamithromycin and Tulathromycin have shown to be efficacious for treatment of animals 
diagnosed with bovine respiratory disease when they are used in accordance with the label
7-12
. 
To our knowledge, this is the first field study comparing gamithromycin vs. tulathromycin for 
treatment of BRDC in feedlot cattle. Due to animal welfare considerations, the present study did 
not include a negative control, so we were unable to compare the antimicrobial efficacy against 
placebo and thus formally assess treatment effect of the antimicrobials. 
In the present study, cattle were considered to be at high risk of developing BRDC. Risk factors 
for BRDC included: initial body weight (233.8±24kg) at arrival, acquisition from auction 
markets, commingling, and stress of transportation. In addition, time of the year at arrival 
(October, November, and December) has been associated with higher risk of developing 
BRDC
19, 20
.  Although information about cattle buyer was available, geographical location of the 
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auction markets was not provided; therefore, we were unable to estimate length and time of 
transportation.  
As expected, no evidence of differences (P≥0.39) between treatment groups at enrollment was 
observed for initial body weight, rectal temperature, or the proportion of animals with fever 
(rectal temperature ≥ 40°C).  Also, the average DOF at enrollment did not differ (P=0.52) 
between treatment groups. Therefore, no evidence of concerns with the randomization approach 
were found, so calves in both treatment groups were considered similar. 
Previous studies comparing antimicrobial efficacy for the treatment of BRDC in cattle have 
evaluated health outcomes during 10, 14, or 28 days after treatment
7,8,9,10,11
.  In order to obtain as 
much data as possible, health outcomes in the present study were evaluated over a period of 120 
days. Interestingly, no re-treatment or fatality cases were observed after 105 days post-treatment. 
In addition, by day 35 post-treatment, cumulative re-treatment rate was 95% of the ultimate total 
number of animals receiving a second treatment (Table 3.3) and case fatality rate was 78% of the 
final number of case fatalities (Table 3.4).  
In the present study, we found that cumulative re-treatment rate during the first 120 days post-
treatment was higher (P<0.01) in animals treated with gamithromycin compared with those 
treated with tulathromycin (Table 3.1). This information agrees with the study conducted by 
Skogerboe who reported differences in cure rates (during 28 days after treatment) comparing two 
single dose injectable macrolides, tilmicosin
r
 and tulathromycin, for the treatment of BRDC
11
; 
however, in that study, differences were found only in one of two sites and no statistical analysis 
were provided across both sites.  Likewise, the study conducted by Kilgore reported that cure 
rate was greater (P<0.01) in animals receiving tulathromycin (78%) compared with those 
receiving tilmicosin (65%) across 4 sites (Texas, Idaho, Nebraska, and California), and within 
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each site
7
. It is important to mention that this study evaluated health outcomes only during 14 
days after treatment.  
In the present study, sites were modeled as random effects to allow for a broad scope of 
inference
18
; therefore, analyses within each site were not conducted. The random effect of site 
and the combination of site × treatment allows us to account for the variability between feedlots 
when performing treatment comparisons; as a result, we can infer across the greater U.S. feedlot 
population for which the participating feedlots might be considered a representative sample
18
.  
For the analysis of re-treatment rate, the interaction of initial BW × treatment, and fever × 
treatment were assessed, but they were dropped from the linear predictor due to non-significant 
contribution to fit the model (P≥0.44). Therefore, the main effect of treatment was the same for 
different  levels of initial body weight and rectal temperature.  
For those outcomes were no evidence of differences were detected (P>0.05) with classical 
hypothesis testing (failing to reject the hypothesis null of no “treatment differences”), we 
conducted a bioequivalence test.  Using this methodology, we concluded on similarities in 
treatment performance within a confidence limit (±mean treatment difference)
22
. Using the 
bioequivalence test, we established bioequivalence of  ±2% for case fatality rate (P < 0.05) 
between gamithromycin and tulathromcyin, indicating that the estimated mean case fatality for 
tulathromycin (3.7±2%) minus the estimated mean of case fatality of gamithromycin (4.2±2%) 
will result in a mean treatment difference between the limits (bioequivalence limits) of ±2.0%. 
Similarly, in the study conducted by Kilgore in 4 feedyards, no evidence of differences in 
mortality rates were  found (P>0.1) between tulathromycin (0.6%) and tilmicosin (1%), across 
sites and within sites
7
. In addition, in the study conducted by Skogerboe in two feedlots, one site 
(Colorado) reported greater mortality rate in animals treated with tilmicosin (6%) compared with 
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those treated with tulathromycin (0%); however, the other site (Texas) reported no evidence of 
differences in mortalities between animals treated with tulathromycin and those treated with 
tilmicosin
11
. 
Average daily gain during the subsequent 120 days after treatment was similar (P < 0.05) for 
animals receiving gamithromycin (1.52±0.06 kg) and those receiving tulathromycin (1.57±0.06 
kg). Likewise, Skogerboe reported that ADG during the first 28 days after treatment was greater 
(P < 0.05) for the animals treated with tulathromycin compared with those treated with 
tilmicosin; however, no evidence of differences between treatments was found in ADG from day 
0 through harvest
11
. Compensatory gain has been shown in previous studies for morbid animals 
after day 135 to 238
1
; this suggests that evaluation of ADG is only relevant if it is measured 
during short periods after treatment. Subsequently, a serial evaluation of ADG at different time 
periods will allow us to identify differences in performance and evaluate compensatory gain.  
Diagnosis of morbid animals is commonly based on clinical signs that include a combination of 
objective (i.e. rectal temperature) and subjective (i.e. depression, abnormal appetite, and 
respiratory signs) animal attributes
20
.  Previous studies have shown that BRDC diagnosis under 
field conditions based on these attributes has low sensitivity and specificity, 61.8 and 62.8% 
respectively
23
.  Consequently, a high degree of diagnosis error is expected.  Thompson found 
that only 55.4% of animals treated once for BRDC had lung lesion at slaughter
24
; similarly, 
Wittum (1996) found that only 78% of steers treated for respiratory disease (either before 
weaning or in the feedlot) had lung lesion at slaughter
25
. Consequently, a big proportion of false-
positive and false-negative can bias the results for morbidity rates. Hence, clinical scores and 
lung lesions at slaughter are poor methods to truly detect diseased animals
23
.  New technologies 
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that increase the sensitivity and specificity of BRDC diagnosis will increase accuracy in 
evaluating morbidity rates in field trials. 
 Conclusion 
Under commercial feedlot conditions, both antimicrobials performed similarly and were 
considered bioequivalent for case fatality rate, average daily gain, and final body weight. 
Nevertheless, calves treated with tulathromycin had lower re-treatment rates compared to 
gamithromycin. 
 Footnotes 
a. Ivomec Plus, Merial LTD, Duluth, GA. 
b. Dectomax, Pfizer Animal Health, New York, NY. 
c. Caliber 7, Boehringer Ingelheim Vetmedica Inc., St. Joseph, MO. 
d. Vision 8, Intervet/Schering-Plough Animal Health, Millsboro, DE. 
e. Vision 7, Intervet/Schering-Plough Animal Health, Millsboro, DE. 
f. Essential 2, Colorado Serum Company, Denver, CO.  
g. Bovishield Gold 5, Pfizer Animal Health, New York, NY.  
h. Express 5, Boehringer Ingelheim Vetmedica Inc., St. Joseph, MO. 
i. Pyramid 5, Boehringer Ingelheim Vetmedica Inc., St. Joseph, MO.  
j. Titanium 5, Agri Laboratories LTD, St. Joseph, MO. 
k. Vista 3 SC, Intervet/Schering-Plough Animal Health, Millsboro, DE. 
l. Component TE- IH, Eli Lilly and Company, Indianapolis, IN. 
m. Revalor G, Intervet/Schering-Plough Animal Health, Millsboro, DE.  
n. Revalor-IH, Intervet/Schering-Plough Animal Health, Millsboro, DE.  
o. Zactran, Merial LTD, Duluth, GA. 
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p. Draxxin, Pfizer Animal Health, New York, NY. 
q. PROC GLIMMIX, SAS, version 9.3, SAS Institute, Cary, NC 
r. Micotil, Eli Lilly and Company, Indianapolis, IN. 
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 Tables 
 
Table 3-1 Least square mean estimates and estimated standard errors of the means for BW 
and rectal temperature (at enrollment), and re-treatment rate (from enrollment through 
day 120 post-treatment) of animals treated for BRDC with tulathromycin and 
gamithromycin 
 
                
  
   
  
      
  
  ITEM Tulathromycin SEM Gamithromycin SEM P-value   
  Initial body weight (kg) 236 1.6 235 1.6 0.41   
  Rectal temperature (°C) 40.2 0.1 40.2 0.1 0.79   
 Days on feed at enrolment 3.7 0.7 3.6 0.7 0.52  
  Re-treatment (%)   9.0 3.9 17.7 6.7 < 0.01  
        
       
 
 
Table 3-2 Least square means estimates (and estimated standard error of the mean) and 
bioequivalence limits for final BW, ADG, and Case fatality rate (from enrollment through 
day 120 day post-treatment) of animals treated for BRDC with tulathromycin and 
gamithromycin 
 
                
     
  
 
   
Bioequivalence   
  ITEM Tulathromycin Gamithromycin SEM Limits (±)
1
   
  Final BW (kg) 456 450 7.0 13.0   
  ADG, (kg/day) 1.57 1.52 0.06   0.1   
 Case fatality rate (%)   3.7 2.4 4.2 2.4  
          
 
  
 
1
 Average bioequivalence between treatments (P<0.05) established within the ±limits  
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Table 3-3 Number of animals that were re-treated (second treatment) for BRDC within the 
first 120 days post-enrollment, across all sites. 
 
              
  Number of calves re-treated   
  
Days post-
enrolment 
Tulathromycin Gamithromycin 
Re-treatment 
by period 
Cumulative  
re-treatment (%)   
  7 5 5 10 5   
  14 35 51 86 49   
  21 12 43 55 77   
  28 14 12 26 90   
  35 5 9 14 97   
  42 0 1 1 98   
  49 0 2 2 99   
  63 0 1 1 99   
  84 0 1 1 100   
  TOTAL 71 125 196 100   
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Table 3-4 Number of animals that died due to BRDC (Case fatality rate) within the first 
120 days post-enrollment that was treated with tulathromycin or gamithromycin, across all 
sites. 
  
     
  
  Number of mortalities   
  
Days post-
enrolment 
Tulathromycin Gamithromycin 
Mortalities 
Total 
Cumulative 
Mortality %   
  7 16 8 24 29   
  14 10 7 17 49   
  21 1 1 2 52   
  28 4 8 12 66   
  35 2 8 10 78   
  42 1 3 4 83   
  49 1 3 4 88   
  56 1 0 1 89   
  70 0 1 1 90   
  77 1 2 3 94   
  84 1 0 1 95   
  91 0 1 1 96   
  98 1 0 1 98   
  105  0 2 2 100   
 
TOTAL 39 44 83 100   
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 Abstract 
This study was conducted to evaluate initial body weight (IBW), rectal temperature, castration, 
and dehorning (tipping) at processing, as factors associated with mortality and morbidity due to 
Bovine Respiratory Disease Complex (BRDC) during the 120 days after arrival. The analysis 
included a total of 3,365 individual animal records from three feedlots located in Kansas 
(n=1,002, BW 479 lb., SD ± 40 lb.), Nebraska (n=1,527, 519 lb., ± 91 lb.), and Texas (n=838, 
572 lb., ± 41 lb.). Generalized linear mixed models were used to fit the categorical binary 
outcomes of mortality and morbidity. The estimated overall morbidity and mortality rates were 
34.5% (SEM ± 4.8%) and 6.7% (SEM ± 1.9%), respectively. The estimated odds of morbidity 
was 1.85 (95% CI= [1.03, 3.32]) greater for castrated bulls compared with steers, given an 
average of 550lb at arrival and controlling for rectal temperature. The estimated odds of 
morbidity and mortality were 1.7 (95% CI = [1.35, 2.02]) times greater for calves with fever 
compared with those with normal temperature, same for steers and castrated bulls. For a 100 lb. 
reduction IBW relative to a baseline of 550 lb., the estimated odds of morbidity was 2.0 (95% CI 
= [1.56, 2.63])  times greater for febrile calves and 1.6 (95% CI = [1.37, 1.93])  times greater for 
calves with normal temperature. A reduction of 100 lb. in IBW relative to a baseline of 550 lb., 
the odds of mortality increased 1.4 (95% CI =[1.06, 1.87 ]) times, regardless of castration status 
and rectal temperature. These estimated odds ratios indicate that calves with lighter weights and 
those with fever at arrival are in a greater risk of death or of developing BRDC during the first 
120 DOF. Also, animals that were castrated at arrival are at higher risk of developing BRDC. No 
evidence of association (P≥0.22) between dehorning and BRDC morbidity and mortality was 
observed. Monitoring rectal temperature and initial body weight can be beneficial tools to 
consider for early diagnosis, treatment, and care interventions of animals with BRDC. 
73 
 
 Introduction 
Bovine Respiratory Disease Complex (BRDC) is the primary cause of illness and death loss in 
feedlot cattle in the United States
28
. The disease accounts for approximately 50% of morbidity 
and 75% of mortalities in feedyards
3,14,27
.  Annual economic losses are estimated in US $1 billion 
due to mortality, morbidity, treatment cost, and reduction in performance and carcass value 
12-14
; 
in addition, it is estimated that the beef industry spends over US $3 billion annually on 
preventive measures
13
.  BRDC is considered a multifactorial syndrome caused by environmental 
factors, individual animal susceptibility, and viral and bacterial pathogens
14,17
. Environmental 
factors, also referred as “stressors”, are necessary to induce naturally occurring BRDC19,27. Stress 
increases glucocorticoids circulating in plasma which results in immunosuppression
1,9,26
. 
Consequently, virus and bacterial pathogens, acting in a synergistic manner, develop the 
bacterial pneumonia
19
. Weather conditions, transportation, weaning, and commingling are the 
most common stressors associated with BRDC mortality and morbidity
2,24,27
; moreover, it has 
been postulated that stress due to castration and dehorning can be associated with BRDC
27
; 
however, this association has not been consistently reported in the literature
10
.  Likewise, animal 
weight at arrival has been reported as a risk factor for BRDC
20,21,23
. Like with castration and 
dehorning, the information is inconsistent and most studies do not report the magnitude of this 
association
27. Besides, BRDC diagnosis is objectively supported by rectal temperature ≥ 104.0 
ºF
22
; therefore, monitoring rectal temperature at processing is a potential tool for early diagnosis 
and treatment of sick animals
11
. However; this practice has potential limitations to identify sick 
cattle because body temperature increases with increasing ambient temperature and humidity and 
animal movement through the handling facility
11,15
. Controlling factors associated with the 
development of BRDC for early diagnosis and treatment is critical to reduce losses due to BRDC 
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and improve animal wellness. The objective of this study was to evaluate rectal temperature, 
castration, dehorning, and IBW at arrival, as factors associated with mortality and morbidity due 
to BRDC in feedlot cattle. 
 Material and methods 
This study did not use animals; therefore, Animal Care and Use Committee approval from 
Kansas State University was not obtained.  
 Animals 
A total of 3,365 individual animal health records from 3 feedyards located in Kansas (n=1,002, 
BW 479 lb., SD ± 40 lb.), Nebraska (n=1,527, 519 lb, ± 91 lb), and Texas (n=838, 572 lb, ± 41 
lb), were used in the analysis.  All calves were acquired from auction markets between October 2 
and December 18, 2010. Animal records included: individual animal identification, date of 
arrival, pen identification, gender, initial body weight (IBW) at arrival, rectal temperature at 
processing, castration and dehorning procedures (only if performed), and mortality and 
morbidity due to BRDC during the first 120 days after arrival.  
Processing and housing 
Upon arrival, calves were processed within 24 hours. At processing, animals were given an ear 
tag for individual identification, vaccinated against clostidial
 
(Kansas
a
, Nebraska
a
 , and Texas
b
) 
and viral pathogens (Kansas
c
, Nebraska
d
 and Texas
e
); in addition, animals were treated for 
internal and external parasites with fenbendazole
f
 and ivermectin
g
 respectively. Also, calves 
were mass treated with an injectable antimicrobial
h,i
 to control BRDC. Animals received an 
anabolic implant in the feedlots located in Kansas
j
 and Texas
k
.  Intact bulls were castrated 
surgically practicing an open technique with the use of a “newberry” knife to cut the scrotum and 
application of an emasculator to crush and cut the testicular cords
5
; furthermore, the tip of the 
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horn (only the keratinized tissue of the horn) was removed using a guillotine shear in those 
animals with large horns
25
 . After processing, animals were assigned to open air group pens 
according to weight and arrival date. Average number of animals per pen was 50 in Kansas, 110 
in Nebraska, and 40 in Texas. Animals were fed with a ration formulated to meet or exceed the 
requirements of the National Research Council for maintenance and expected growth
18
.  All 
animals had ad libitum access to water. 
 Health outcomes for BRDC. 
General health observations were performed daily by pen riders from day 0 through day 120 
after arrival.  Morbidity due to BRDC included animals showing clinical scores of 1, 2 or 3 
according to the clinical score scale (table 4.1) and having rectal temperature equal to or greater 
than 104ºF. Sick animals received antimicrobial medication according to the standard feedlot 
procedures and returned to their home pens.  Moribund animals were euthanized following the 
guidelines of the Animal Welfare Committee of the American Association of the Bovine 
Practitioners. Mortality attributed to BRDC during the first 120 days on feed was confirmed by 
presence of bronchopneumonia at necropsy of those animals that either died or were humanely 
euthanized. 
Statistical Model 
Mortality and morbidity due to BRDC were fitted using generalized linear mixed models using a 
logit link function for binomial responses.  For morbidity, the linear predictor in the model 
included the fixed effects of temperature status at arrival (Normal: < 104 °F, or Fever: ≥ 104 °F), 
castration and dehorning procedures (Castration:Yes/No, and Dehorning:Yes/No), and IBW at 
arrival was included in the model as a covariate. In addition, pen nested within feedlot was used 
as random effect. Also, gender (male or heifer) was evaluated as a fixed effect; however, it was 
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dropped due to non-substantial contribution (P=0.60) to fit the model. Finally, the interaction of 
rectal temperature × IBW was used to model fit due to its marginal contribution (P = 0.09).  
For mortality, the linear predictor in the model included rectal temperature status at arrival, and 
castration and dehorning procedures as fixed effects; also, IBW was used as a covariate.  Pen 
nested within feedlot was used as random effect.  Two way interactions between fixed effects 
and covariate IBW were evaluated to fit the model; however, they were dropped due to non-
significant (P≥0.57) contribution to fit the model. Parameter estimates from the statistical models 
described above were used to conduct classical hypothesis testing. Effects were considered 
significant based on P-values < 0.05 on the corresponding ANOVA Type III F-test statistics; 
marginal evidence of main effects was declared at P < 0.10.  
All statistical models were fitted using the GLIMMIX
l
 procedure of SAS (Version 9.3, SAS 
Institute, Cary, NC). Kenward-Roger’s approximation was used to estimate degrees of freedom 
and to make the corresponding adjustments in estimation of standard errors. 
Results 
During the 120 days after arrival, the estimated morbidity and mortality rates were 34.5% (SEM 
± 4.8%) and 6.7% (SEM ± 1.9%), respectively. At arrival, a total of 608 (18%) animals were 
identified with fever, and 2,757 (82%) animals had normal rectal temperature.  
A total 113 calves (7.4%) were dehorned (tipped) and 51 calves (3.3%), purchased as bulls were 
surgically castrated. There was no evidence of a main effect (P≥ 0.22) of dehorning on BRDC 
mortality and morbidity. For morbidity rate, parameter estimates were significant for the main 
effects of castration (P= 0.04), rectal temperature status at processing (P=0.02), and  the 
covariate IBW at arrival (P<0.01). 
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The estimated odds ratio of morbidity due to BRDC was 1.85 times greater (95% CI= [1.03, 
3.32]) in castrated bulls compared with steers, controlling for fever status and a given average 
BW of 550 lb. at arrival. Likewise, the estimated odds ratio of morbidity was 1.7 greater (95% 
CI = [1.35, 2.02]) in calves with fever at processing compared with those with normal rectal 
temperature, same for castrated bulls and steers and given an average arrival BW of 550 lb.  
The estimated odds of  BRDC morbidity was 2.03 (95% CI = [1.56, 2.63]) greater for a reduction 
of 100 lb. of IBW, relative to a baseline of 550lb., and same for castrated bulls or steers and 
regardless rectal temperature at arrival.  
These estimated odds ratios indicate that animals with lighter weights, animals that were 
castrated, and those with fever at arrival are at a greater risk of developing BRD during the first 
120 days after arrival.  Consequently, estimated morbidity rate estimates were greater for light 
weight calves compared with heavier animals.  
For BRDC mortality, no evidence of effects of castration (P = 0.24) or dehorning (P = 0.22) 
were found.  Nonetheless, IBW (P < 0.02) and fever status at arrival (P < 0.01) were associated 
with BRD mortality. Consequently, for a reduction of 100lb. in initial BW relative to a baseline 
of 550lb, the odds of mortality increased 1.4 (95% CI =[1.06, 1.87 ]) times, regardless rectal 
temperature status, castration, or dehorning procedures.  Likewise, animals with fever at arrival 
had an estimated odds of mortality 1.6 (95% CI= [1.1, 2.2]) times greater than the odds of 
mortality in animals with normal temperature, regardless castration or dehorning procedures, and 
given an average of 550lb. of IBW. 
The odds ratio estimate indicates that animals with lighter weights and fever at arrival are at 
greater risk of mortality due to BRD during the first 120 days after arrival.  Also, the estimated 
morbidity rate was greater in lighter calves compared with heavier animals (Figure 4.2).  
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Discussion 
At arrival, castration of intact bulls is performed to meet the beef industry standards
6
. Castration 
reduces aggression and mounting behavior of males and improves beef quality
8
; however, 
castration is a painful procedure that affects animal well-being and produces stress
6,9,10
, and it 
can negatively impact health status
7,27
 In the present study, the odds ratio estimate for castration 
indicates that bulls castrated at arrival were at higher risk of develop BRDC during the first 120 
DOF compared with steers. This result agrees with the study conducted by Coetzee et al., (2012), 
who reported that castrated animals had greater BRDC incident compared with steers. Another 
study conducted two experiments to evaluate the effects of castration on health and 
performance
4
. In experiment one (n=105 calves) morbidity (animals that were pulled) and 
treatment (animals that were pulled and treated) rates were greater in calves that were castrated 
surgically compared with those that were purchased as steers; however, the second experiment 
(n=283 calves) reported no differences in first treatment or retreatment rates among bulls that 
were banded or surgically castrated and calves that were purchased as steers. In the present 
study, dehorning (tipping) was not associated with BRDC morbidity (P = 0.61) or mortality (P = 
0.22). This finding disagrees with Martin et al., (1998) which reported that BRDC cases were 
30% greater in calves that were dehorned compared with those not dehorned; however, the 
method of dehorning was not reported in that study. If it is performed accurately, tipping is less 
painful compared with horn amputation because tipping does not affect the pain-sensitive core of 
the horn
16,25
; this is the reason that we were not able to detect evidences of associations between 
tipping and BRDC. In addition, since there were no animals that were castrated and dehorned at 
the same time; the dehorning × castration interaction could not be tested. 
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In the present study, the odds ratio for initial BW estimate indicates that animals with lighter 
weights at arrival are at a greater risk of mortality due to BRD during the initial 120 DOF. This 
result agrees with one study that reported that calves weighing more than 318 kg were less likely 
to develop BRD (relative risk of 0.18), compared with calves weighing less than 218 kg
21,23
. 
Likewise, other authors have reported that animals categorized as yearlings have lower incidence 
of BRDC morbidity and mortality compared with calves
27
; however, animal age is difficult to 
monitor resulting in an arbitrary categorization of age. Body weight is an objective, easily-
measured, animal characteristic that can be used as a factor to predict cattle health. Figures-1 and 
2 show that IBW is not linearly correlated with BRDC morbidity and mortality. It has been 
postulated that monitoring rectal temperature has limited value in identifying morbid animals
15
 
because rectal temperature is affected by ambient temperature, humidity, and animal handling at 
processing
11
. In the present study, animals with fever at processing were at greater risk of death 
or to develop BRDC compared with those animals with normal temperature. This agrees with 
one study that evaluated metaphylactic antimicrobial administration compared with antimicrobial 
treatment given only to animals showing rectal temperature ≥ 39.7 °C (103.5°F). That study 
reported that monitoring rectal temperature was effective in reducing treatment cost, and 
reported no differences in performance or health outcomes between treatment groups
11
. 
Monitoring rectal temperature at arrival can be a potential tool for early diagnosis, treatment, and 
target management practices for animals with BRDC. 
 Conclusions 
Calves with lighter weights and fever at arrival are at greater risk of mortality and morbidity due 
to BRD during the first 120 days after arrival.  Also, castrated bulls are at higher risk of 
developing BRDC. These findings suggest that lighter calves require special attention and 
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veterinary interventions for early diagnosis and treatment of the disease.  In addition, monitoring 
rectal temperature at arrival can be beneficial for treatment interventions of sick cattle.  Then, 
minimize economic losses and animal welfare concerns due to BRDC in feeder cattle. 
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 Footnotes 
 
a
 Vision 7/Somnus, Intervet/Schering-Plough Animal Health, Millsboro, DE 
b  
Essential 2, Colorado Serum Company, Denver, CO. 
c
 Bovishield Gold 5, Pfizer Animal Health, New York, NY.  
d
 Inforce 3, Pfizer Animal Health, New York, NY . 
e
 Titanium 3, Agrilabs, St. Joseph, MO. 
f
 SafeGuard, Intervet/Schering-Plough Animal Health, Millsboro, DE. 
g 
Ivomec Plus, Merial LTD, Duluth, GA. 
h
 Zactran, Merial LTD, Duluth, GA. 
i
 Draxxin, Pfizer Animal Health, New York, NY. 
j
 Ralgro, Intervet/Schering-Plough Animal Health, Millsboro, DE. 
k
 Component TE-IH, Eli Lilly and Company, Indianapolis, IN. 
l
 PROC GLIMMIX, SAS, version 9.3, SAS Institute, Cary, NC 
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 Tables 
 
Table 4-1 Clinical Score Scale for animals with BRDC 
 
               
                   
  Score Description   
  
0 Normal:  Nothing unusual in animal’s attitude and no abnormal 
respiratory symptoms present.    
  
1 Mild depression (somewhat slow coming to feed bunk, but did 
eat).  Mild respiratory symptoms present; serous nasal or ocular 
discharge and/or caugh.   
  
2 Moderate depression (slight head/ears dropping, reluctant to move 
about, reluctant to come to the feed bunk).  Moderate respiratory 
distress:  Mucosus or mucopurulent nasal or ocular discharge 
and/or increase in respiratory rate or effort.   
  
3 Severe depression (pronounced head/ear droop’ very reluctant to 
move).  Severe respiratory distress: marked increase in respiratory 
rate or effort including: open mouth breathing, abdominal 
breathing, or extended head)   
  4 Moribund   
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 Figures 
 
Figure 4-1 Estimated BRDC morbidity rate by IBW at arrival in steers and castrated bulls. 
Main effects of castration (P= 0.04) and initial body weight at arrival (P<0.01) were 
associated with BRDC morbidity. CASTRATED (animals that arrived at the feedyard as 
intact bulls and were surgically castrated), STEERS (animals that arrived at the feedyard 
as steers). 
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Figure 4-2 Estimated BRDC morbidity rate by IBW at arrival in animals with fever or 
normal temperature. Main effects of rectal temperature status at processing (P=0.02), and 
initial body weight at arrival (P<0.01) were associated with BRDC morbidity. Marginal 
interaction of IBW × rectal temperature (P = 0.09).  NORMAL (animals that had rectal 
temperature <104°F at processing), FEVER (animals that had rectal temperature ≥104°F 
at processing). 
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Figure 4-3 Estimated BRDC mortality rate by IBW at arrival. Rectal temperature status at 
arrival (P < 0.01) and IBW (P < 0.02) were associated with BRD mortality. Main effects of 
castration (P= 0.04), rectal temperature status at processing (P=0.02), and initial body 
weight at arrival (P<0.01) were associated with BRDC morbidity. NORMAL TEMP 
(Calves with rectal temperature <104°F) and FEVER (Calves with rectal temperature 
≥104°F). 
0%
5%
10%
15%
20%
25%
200 250 300 350 400 450 500 550 600 650 700 750 800
M
o
rt
al
it
y 
d
u
e
 t
o
 B
R
D
C
 (
%
)
Body Weight ar Arrival (lb)
NORMAL TEMP FEVER
 
88 
 
Chapter 5 - Statistical Process Control for monitoring mortality 
associated with Respiratory Disease Complex in feedlot cattl. 
1
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 Introduction 
Statistical Process Control (SPC) is a powerful tool for monitoring and controlling processes and 
outcomes through statistical methods
1
.  It has been used for more than 80 years in the 
manufacturing and human health care industries
2
; however, its application in food animal 
agriculture has not been extensively implemented
2
. The production systems in the food animal 
industry are based on standardized operating procedures (SOP) and management practices; SOP 
outcomes can be easily measured and monitored
2
. Statistical process control can be used for 
monitoring SOP outcomes, health parameters, and animal performance which would benefit top 
management and animal care personnel in the feedlot industry to define normal variation, 
identify abnormal deviations, and make interventions to reduce the negative impact of special 
extreme cases of variation. 
 One of the most important SPC tools for monitoring and analysis is the control chart.  
The foundation of control charts is rooted in the theory of variation, understanding and defining 
what “normal” variation is, and identifying “special cases” of variation3.  In livestock, the initial 
published information about the use of SPC was in the swine industry
4
. In the cattle industry, 
SPC has been implemented in dairies as a method to control mastitis, milk quality, bulk-tank 
milk somatic cell counts, and reproductive performance
5
.  In beef cattle, SPC has been reported 
to monitor carcass quality
6
, steer weight gain
7
, and feeding behavior of newly received calves
8
.  
However, to our knowledge, no additional SPC reports on beef cattle have been published. 
 Profitability in cattle operations is affected by economic losses due to animal health 
conditions and/or animal performance deviations
5
.  Developing an SPC system to monitor, 
evaluate, and analyze health and performance parameters in feedlot cattle will provide a tool to 
identify and differentiate between “normal” and “abnormal” cases of variation.  Hence, 
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veterinarians and other cattle care personnel can implement interventions to reduce the impact of 
potential losses and improve animal health and productivity. 
 Record keeping in feedlot operations is a common practice. Nonetheless, record keeping 
by itself does not imply that actions will be, or should be, performed to improve health and 
performance. Experience has shown that SPC principles, in conjunction with other management 
practices, can be applied in cattle production medicine and can become a very powerful tool for 
continuous improvement
2
.  The objective of this study is to develop control charts based on the 
SPC principles and other statistical tools to define “normal” variation for mortality due to BRDC 
in feedlot cattle, and identify, and describe abnormal “special cases of variation”. 
 Material and methods 
This study did not use animals; therefore, Animal Care and Use Committee Approval from 
Kansas State University was not obtained.  
 Database 
This study is a retrospective study of commercial feedlot production data.  A total of 359,344 
individual animal records from 7 commercial feedlots, 4 located in Kansas (KAN1, KAN2, 
KAN3, KAN4) and 3 located in Nebraska [NEB1, NEB2, NEB3 [table 1]), were used in the 
analysis.  Data were collected over a period of 32 months (Jan 2009 to Aug 2011). Individual 
animal records included animal identification, date of arrival, body weight (BW, lb) at arrival, 
and lot identification. Also, each lot contained information about the source (city & state of 
origin) and feedlot location.  In addition, individual records contained information for mortality 
due to BRDC (over the entire feeding period). Animals that died due to Acute Interstitial 
Pneumonia were not included in the analysis.  Lot consisted of an identified cohort of animals 
that arrived at the feedyard from a single source of origin on the same day; however, they may or 
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may not have been allocated to the same pen; consequently, information from each individual 
pen was not available. 
A total of 96 lots (2,737 animals) were removed from analysis because each lot contained less 
than 40 animals within each lot.  In addition, 23 lots (14,390 animals) were removed because 
they were considered too large for analysis (containing more than 500 animals per lot). After this 
consideration, a total of 342,217 animals were included in the analysis. Furthermore, animal 
gender categorized as “Holstein” or those with “unknown” gender or source were not included in 
the final dataset.  In addition, animals that received metaphylaxis at arrival for control of BRDC 
were removed from the dataset.  Finally, animals with initial BW greater than 1300 lb 
(“heiferettes”) were excluded from the analysis. 
Geographical region of origin was categorized as southeast (SE; Alabama, Arkansas, southeast 
Kansas, Florida, Georgia, Kentucky, Mississippi, Missouri, North Carolina, Tennessee, Virginia, 
and east-Texas),  west (W; Arizona, California, Idaho, Montana, New Mexico, Utah, 
Washington, Wyoming, and western-Colorado), north east (NE; Illinois, Indiana, Iowa, 
Minnesota), south central (SC; eastern-Colorado, central and western Kansas, Oklahoma, and 
west-Texas), north central (NC; Nebraska, North Dakota, South Dakota), and Canada. Length of 
transportation (miles) was calculated using google maps (www.maps.google.com), and it 
consisted in the distance between the cities of origin to the feedlot location. In those source-
locations where source only was specified as state or country, the city of origin was selected as a 
central point from the state of interest; as a result, length of transportation was categorized as 
short haul (SHORT; ≤ 250 mi), medium haul (MEDIUM; between 250 and 550 mi), and long 
haul (LONG; >550 mi). Furthermore, season of arrival was categorized as winter (WIN; 
December, January, and February), spring (SPR; March, April, and May), summer (SUM; June, 
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July, and August), and fall (FALL; September, October, and November). Finally, initial body 
weight (BW) was categorized as light weight calves (LIGHT; BW ≤ 550 lbs.), medium weight 
(MEDIUM; BW between 550 lbs. and 750 lbs.), and heavy (HEAVY; BW ≥ 750 lbs.). 
Monitoring mortality rate across lots with control charts 
Control charts based on time-series graphs were developed for each feedlot to monitor mortality 
rates across lots, establish control limits, and identify normal and special cases of variation. 
Typically, in a time-series chart, time (e.g. months, weeks, days, etc.) are marked off on the 
horizontal axis (x), and the values to monitor (e.g. morbidity and mortality rates) are marked in 
the vertical (y) axis. As a result, time passage in the time series graph is moving from left to right 
on the horizontal axis. The overall mean ([ ; known as the central line in the time series chart) 
is computed using the average of the observations. Traditionally, the upper control limit (UCL) 
and lower control limit (LCL) are computed using a “three sigma limit” methodology. 
Consequently, the UCL is computed by multiplying the standard deviation (SD) by a fixed factor 
of 3.0 and adding the product to the overall mean (UCL =  + [3 × SD]);  the LCL is obtained 
by multiplying the standard deviation (SD) by a fixed factor of 3.0 and subtracting the product to 
the overall (LCL =  - [3 × SD])
9
. 
In the present study, lots were sequentially numbered by date of arrival to the feedyard and 
marked off in the horizontal (x) axis, like a time-series graph. The values for mortality rates (%) 
were marked in the vertical (y) axis. As a result, a time-series-type chart was used to identify 
normal variation and special cases of variation (SCV) for mortality rates. The overall mean in 
these control charts ( ) corresponded to the average mortality rate across all lots within each 
feedyard, during the entire period of analysis (Jan 2009 to Aug 2011).  The upper control limit 
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(UCL) was computed using the “three sigma limit” methodology, and it was obtained by 
multiplying the standard deviation (SD) by 3.0 and adding the product to the overall mean 
[UCL= .  The overall mortality mean ( ) and standard deviation was computed 
using Microsoft Excel. The LCL was established at zero mortality rates since this is the lowest 
meaningful value that was considered normal variation. 
Results 
A total of 342,217 animals (2,286 lots) were included in the data set.  Animals originating in the 
geographical regions of SE, SC, NC, CANADA, and WEST made up 44% (149,005 animals), 
21% (72,298 animals), 14% (49,306 animals), 7% (24,944 animals), and 5% (17,774 animals) of 
the animals in the dataset (Table 5.1).  
In the control charts for monitoring mortality rates across lots within each feedyard, mean 
mortality rate ( ), standard deviation (SD), and UCL was established for KAN01 ( 0.62%; 
SD=1.76%; UCL=5.59%), KAN02 ( 0.13%; SD=0.69%; UCL=2.23%), KAN03 ( 1.10%; 
SD=1.99%; UCL=7.08%), KAN04 ( 0.52%; SD=1.02%; UCL=3.60%), NEB01 ( 0.21%; 
SD=0.51%; UCL=1.75%), NEB02 ( 0.28%; SD=0.65%; UCL=2.23%), and NEB03 
( 0.41%; SD=0.94%; UCL=3.24%) Figures 5.1 – 5.7, table 5.2.  Across all locations, special 
cases of variation (SCV) accounted for less than 2.2% of the total lots placed, thus indicating that 
at least 97.8% of the lots were considered within the “normal” variation for mortality rate. 
For the analysis of geographical region of origin across all feedlot locations, the proportion of 
placements with lots considered within the limits of “normal” variation for mortality rate ( ) 
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originated in the SE (43%; =0.36%), SC (21%; =0.47%), NC (14%;  =0.26%); EAST (9%, 
=0.32%), CANADA (7%; =0.12%) and WEST (5%; =0.17%); the proportion of 
placements from lots considered as SCV originated in the SE (64%; =5.54%), SC (11%; 
=9.32%), NC (10%; =5.11%); EAST (5%, =4.16%), and WEST (11%; =4.41%) region; 
no SCV were identified in CANADA; Table 5.3). The region with the greatest mortality rates 
was SC (  =0.47% and  =9.32%, for “normal” and SCV, respectively). 
From the analysis of season of arrival across all feedyards, the proportion of placements 
considered “normal” that arrived on WIN, SPR, SUM, and FALL was 21%, 28%, 28%, and 
23%, respectively. For those lots considered SCV, animals arriving in WIN, SPR, SUM, and 
FALL made up 22%, 11%, 31%, and 36%, respectively.  It is important to notice that the 
proportion of “normal” placements which arrived during the fall was 23%; however, fall 
placements constituted 36% of SCVs; conversely, “normal” placements arriving during the 
spring made up 28% of all “normal” placements, but spring placements made up only 11% of 
SCVs. The mean mortality rate for “normal” cattle was greater during the FALL ( = 0.45%), 
than the rest of the seasons (SUM= 35%; WIN=0.34%; SPR = 0.27%), table 5.3. 
Across all feedyards, the proportion of LIGHT, MEDIUM, and HEAVY placements which had 
“normal” mortality was 11%, 52%, and 37%.  Lots which were categorized as LIGHT, 
MEDIUM, and HEAVY made up 31%, 62%, and 6% of lots considered SCV.    There was a 
greater proportion of light weight animals that were considered SCV (31% of the placements) 
compared with those light weight animals considered “normal” (11% of the placements), and 
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although HEAVY animals made up 37% of “normal” placements, they only represented 6% of 
SCV (table 5.3). 
For the analysis of distance of transportation (haul) across all feedyards, the proportion of 
“normal” placements with SHORT, MEDIUM, and LONG haul was 22%, 28%, and 51%, 
respectively. For the lots considered as SCV, the proportion of SHORT, MEDIUM, and LONG 
haul was 7%, 27%, and 66% (table 5.3). 
 Potential Applications 
As an example of the application of SPC, 2 feedyard locations, one with the greatest mean 
mortality rate (KAN02) and another with the lowest mean mortality rate (KAN03), were selected 
for analysis. Mortality rate was plotted in a single control chart for comparison purposes (figure 
5.8). Interestingly, overall mean mortality rate was 8 times greater for KAN03 ( 1.10%) than 
for KAN02 ( 0.13%). Likewise, the UCL was greater (3.2 times) for KAN03 (7.08%) 
compared with KAN02 (2.23%). Surprisingly, in both feedyards, 95% of the placements were 
originated from the same geographical regions (southeast and south-central) of the U.S. (Table 
5.1). 
Considering KAN02 as reference feedlot “benchmark”, the UCL of 2.23% mortality rate was 
used in both feedyards to identify “normal” and special cases of variation.  With this unique 
UCL (2.3%) for both feedlots, a new set of lots considered within the limit of “normal” variation 
and lots considered SCV in feedlot KAN03, whereas lots in the site KAN02 did not change.  
With this new UCL in KAN03, a total of 195 lots were considered “normal”, and 35 lots (26%) 
were considered SCV. For those lots considered “normal”, the proportion of cattle originating in 
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EAST, SE, SC, and WEST, was 1%, 51%, 48% and 1%, respectively.  In lots considered SCV, 
cattle originated in SE and SC and accounted for 43% and 53% of the lots. 
The proportion of “normal” lots placed in WIN, SPR, SUM, and FALL were 17%, 35%, 29%, 
and 18%, respectively.  For those lots considered SCV, placement during the FALL accounted 
for 43% of the placements.  The proportion of “normal” lots that were considered LIGHT, 
MEDIUM, and HEAVY were 21%, 50% and 30%, respectively.  For those lots classified as 
SCV, the proportion of LIGHT, MEDIUM, and HEAVY was 25%, 69%, and 6%, respectively.  
For lots considered “normal”, cattle categorized al LIGHT had the greatest mortality rate 
( 0.57%) and cattle categorized as HEAVY had the lowest mortality rate ( 0.26%). For the 
analysis of distance of transportation, the proportion of “normal” lots categorized as SHORT, 
MEDIUM, and LONG haul were 7%, 59%, and 33%, respectively.  Only MEDIUM (51%) and 
LONG (49%) haul accounted for lots considered SVC, Table 5.4. 
 Conclusions 
In the present study, the use of a UCL from KAN02 as a “benchmark feedlot” (based on an UCL 
from a feedyard with the lowest mean mortality rate with similar cattle demographics) was 
effective in identifying “alarm-signal” lots based on source of origin. One limitation of the 
present study is that we were unable to categorize death loss at different days on feed after 
arrival (e.g. 30 days, 60 days, 90 days). 
A potential use of SPC in early detection of special cases of variation (extreme mortality and 
morbidity rates) is through establishing “normal” and UCL for mortality and morbidity rates at 
target days on feed after arrival.  Then, estimation of mortality and morbidities in further stages 
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of the feeding period can be predicted; this information can be valuable for purchasing, 
economic, and financial decisions based on health and performance of the cattle. 
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Table 5-1 Total number of animals and proportion (%) of animals that were placed in 7 
commercial feedyards (located in Kansas and Nebraska) that arrived between January 
2009 through August 2011 from different geographical regions
1
 of origin categorized as 
CANADA, EAST, NC (north-central), SC (south-central), SE (southeast), and WEST.  
          
  Total number of animals placed at feedlot,  
according region of origin 
  
 LOCATION CANADA EAST NC SE SC WEST Total  
 KS01 ---------- 71 48 12,436 34,686 ---------- 47,241  
 KS02 ---------- 85 ---------- 15,941 7,390 1,179 24,595  
 KS03 ---------- 131 ---------- 12,060 16,373 189 28,753  
 KS04 ---------- 2,203 3,569 51,217 9,152 3,920 70,061  
 NEB1 22,837 5,173 29,670 448 717 1,139 59,984  
 NEB2 2,107 5,095 14,497 1,872 534 11,347 35,452  
 NEB3 ---------- 16,132 1,522 55,031 3,446 ---------- 76,131  
 Total (animals) 24,944 28,890 49,306 149,005 72,298 17,774 342,217  
          
          
  Proportion (%) of animals placed at feedlot,  
according region of origin 
  
 LOCATION CANADA EAST SC SE SC WEST Total (%)  
 KS01 ---------- 0  0 26 73 ---------- 100  
 KS02 ---------- 0 ---------- 65 30 5 100  
 KS03 ---------- 0 ---------- 42 57 1 100  
 KS04 ---------- 3 5 73 13 6 100  
 NEB1 38 9 49 1 1 2 100  
 NEB2 6 14 41 5 2 32 100  
 NEB3 ---------- 21 2 72 5 ---------- 100  
 Total (%) 7 8 14 44 21 5 100  
          
 
1
 Region of origin was categorized as southeast (SE; Alabama, Arkansas, Florida, Georgia, 
Kentucky, Mississippi, Missouri, North Carolina, Tennessee, Virginia, and east-Texas),  west 
(WEST; Arizona, California, Idaho, Montana, New Mexico, Utah, Washington, Wyoming, and 
western-Colorado), north east (NE; Illinois, Indiana, Iowa, Minnesota), south central (SC; 
western-Colorado, Kansas, Oklahoma, and west-Texas), north central (NC; Nebraska, North 
Dakota, South Dakota), and Canada. 
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Table 5-2 Mean mortality rate (%) and corresponding standard deviation (SD, [%]), upper 
control limit (UCL, [%]), special cases of variation (SCV, [lots]), total number of lots 
placed and proportion of lots identified as SCV in 7 feedyards located in Kansas and 
Nebraska. 
 
                  
  LOCATION Mean
1
 SD
2
 UCL
3
 SCV
4
 
Total 
lots 
Proportion 
of lots SCV 
5
 
  
  KS01 0.62 1.76 5.89 7 320 2.2   
  KS02 0.13 0.69 2.23 6 286 2.1   
  KS03 1.10 1.99 7.08 4 230 1.8   
  KS04 0.52 1.02 3.6 13 572 2.3   
  NEB1 0.21 0.51 1.75 2 315 0.6   
  NEB2 0.28 0.65 2.23 4 219 1.8   
  NEB3 0.41 0.94 3.24 21 942 2.2   
  
 
  
 
 
   
  
 
1 
Mean = Average of mortality rate across all lots   
  
2
 SCV = Special cases of variation (mean mortality rate > UCL)  
  
3 
SD = Standard deviation   
  
4 
UCL = Upper Control Limit (Mean + [SD × 3])   
  
5 
Proportion of SCV (number of SCV [lots] divided be the total number of 
lots within each feedlot) 
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Table 5-3 Placements categorized as “normal” or special cases of variation (SCV) that 
arrived to 7 feedlots located in Kansas and Nebraska, categorized by region of origin
1
 
(Canada, east, north-central, south-central, and west) season of arrival
2
 (WIN, SPR, SUM, 
and FALL), initial BW (LIGHT [BW ≤ 550 lb], MEDIUM [BW between 550 lb and 750 lb], 
or HEAVY [BW > 750lb]), and distance of transportation (SHORT, ≤ 250 mi; MEDIUM; 
between 250 and 550 mi, and LONG > 550 mi). 
            
  Placements categorized as normal 
(mortality rate < UCL) 
 Placements categorized as SCV 
(mortality rate ≥ UCL) 
 
  Number 
of 
animals 
placed 
Percent of 
normal 
lots 
placed 
# of 
lots 
placed 
Mean 
percent 
mortality 
(%) 
 Number 
of 
animals  
Percent 
of 
SCV 
lots 
# of 
lots 
Mean 
percent 
mortality 
(%) 
 
 CANADA  24,944  7 134 0.12  ------ ------ -- ------  
 EAST  28,629  9 267 0.32   261  5 3 4.16  
 NC  48,765  14 294 0.26   541  10 4 5.11  
 SE  145,473  43 1507 0.36   3,532  64 41 5.54  
 SC  71,698  21 521 0.47   600  11 5 9.32  
 WEST  17,183  5 105 0.17   591  11 5 4.41  
 TOTAL  336,692  100 2828 0.35   5,525  100 58 5.67  
            
 WIN  71,254  21 552 0.34   1,196  22 12 5.10  
 SPR  94,123  28 812 0.27   618  11 7 5.62  
 SUM  93,849  28 829 0.35   1,733  31 19 6.27  
 FALL  77,466  23 635 0.45   1,978  36 20 5.44  
 TOTAL  336,692  100 2828 0.35   5,525  100 58 5.67  
            
 LIGHT  37,797  11 390 0.42   1,736  31 18 5.15  
 MEDIUM  173,787  52 1478 0.40   3,447  62 35 5.97  
 HEAVY  125,108  37 960 0.23   342  6 5 5.42  
 Total  336,692  100 2828 0.35   5,525  100 58 5.67  
            
 SHORT  72,670  22 1597 0.32   395  7 41 5.69  
 MEDIUM  93,247  28 688 0.44   1,488  27 14 5.87  
 LONG  170,775  50 543 0.32   3,642  66 3 4.32  
 Total  336,692  100 2828 0.35   5,525  100 58 5.67  
            
 
1 
Region of origin was categorized as southeast (SE; Alabama, Arkansas, Florida, Georgia, 
Kentucky, Mississippi, Missouri, North Carolina, Tennessee, Virginia, and east-Texas),  west 
(WEST; Arizona, California, Idaho, Montana, New Mexico, Utah, Washington, Wyoming, and 
western-Colorado), north east (NE; Illinois, Indiana, Iowa, Minnesota), south central (SC; western-
Colorado, Kansas, Oklahoma, and west-Texas), north central (NC; Nebraska, North Dakota, South 
Dakota), and Canada. 
 
 
2 
Season was categorized as winter (WIN), spring (SPR), summer (SUM), and fall (FALL)  
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Table 5-4 Placements categorized as “normal” or special cases of variation (SCV) that 
arrived at 2 feedlots located in Kansas (KAN02 and KAN03) categorized by region of 
origin
1
 (east, southeast, south-central, and west) season of arrival
2
 (WIN, SPR, SUM, and 
FALL), initial BW (LIGHT [BW≤550 lb], MEDIUM [BW between 550 lb and 750 lb], or 
HEAVY [BW > 750lb]), and distance of transportation (SHORT, ≤250 mi; MEDIUM; 
between 250 and 550 mi, and LONG>550 mi). 
            
  Placements categorized as normal in 
KAN03 (mortality rate < UCL) 
 Placements categorized as SCV in 
KAN03  (mortality rate ≥ UCL) 
 
  Number 
of 
animals 
placed 
Percent 
of normal 
lots 
placed 
# of 
lots 
placed 
Mean 
percent 
mortality 
(%) 
 Number 
of 
animals 
placed 
Percent 
of normal 
lots 
placed 
# of 
lots 
placed 
Mean 
percent 
mortality 
(%) 
 
 EAST 131 1 1  0.76    -   -     
 SE 10,405 51 99  0.41   1655 43 15  4.2   
 SC 13,041 48 93  0.61   3332 57 20  4.7   
 WEST 189 1 2  -      -   -     
 TOTAL 23,766 100 195  0.50   4,987 100 35  4.4   
      -         -     
 WIN 4,064 17 34  0.40   929 17 6  3.4   
 SPR 8,104 35 69  0.46   593 14 5  5.1   
 SUM 6,522 29 57  0.67   2,388 43 15  4.2   
 FALL 5,076 18 35  0.41   1,077 26 9  5.2   
 TOTAL 23,766 100 195  0.50   4,987 100 35  4.4   
      -         -     
 LIGHT 4,683 21 40  0.57   1,222 26 9  3.7   
 MEDIUM 12,258 50 97  0.61   3,589 69 24  4.8   
 HEAVY 6,825 30 58  0.26   176 6 2  3.0   
 Total 23,766 100 195  0.50   4,987 100 35  4.4   
      -         -     
 SHORT 2,069 7 14  0.15   ---- ---- ----  ----   
 MEDIUM 14,387 59 116  0.54   2,579 51 18  3.9   
 LONG 7,310 33 65  0.50   2,408 49 17  5.0   
 Total 23,766 100 195  0.50   4,987 100 35  4.4   
            
 
1 
Region of origin was categorized as southeast (SE; Alabama, Arkansas, Florida, Georgia, 
Kentucky, Mississippi, Missouri, North Carolina, Tennessee, Virginia, and east-Texas),  west 
(WEST; Arizona, California, Idaho, Montana, New Mexico, Utah, Washington, Wyoming, and 
western-Colorado), north east (NE; Illinois, Indiana, Iowa, Minnesota), south central (SC; 
western-Colorado, Kansas, Oklahoma, and west-Texas), north central (NC; Nebraska, North 
Dakota, South Dakota), and Canada. 
 
 
2 
Season was categorized as winter (WIN), spring (SPR), summer (SUM), and fall (FALL)  
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Figure 5-1 Control Chart for mortality rate (percent) by lot number (sequentially 
numbered by arrival date; n=320 lots [47,241 animals]) within a commercial feedlot located 
in Kansas (KAN1); placed from February 2010 through August 2011)). Mean mortality 
rate = 0.6%, SD=1.8%, and upper control limit (i.e. Mean + 3 SD) = 5.9% 
 
  
 
 
Upper Control Limit = 5.9% 
Mean Mortality 
= 0.6% 
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Figure 5-2  Control Chart for mortality rate (percent) by lot number (sequentially 
numbered by arrival date; n=286 lots [24,595 animals]) within a commercial feedlot located 
in Kansas (KAN2); placed from January 2009 through July 2011)). Mean mortality rate = 
0.2%, SD=0.7, and upper control limit (i.e. Mean + 3 SD) = 2.2%  
 
 
 
Upper Control Limit = 2.2% 
Mean Mortality = 0.2% 
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Figure 5-3 Control Chart for mortality rate (percent) by lot number (sequentially 
numbered by arrival date; n=219 lots [27,328 animals]) within a commercial feedlot located 
in Kansas (KAN3); placed from October 2009 through July 2011)). Mean mortality rate = 
1.1%, SD=2.0, and upper control limit (i.e. Mean + 3 SD) = 7.1% 
 
  
 
Upper Control Limit = 8.3% 
Mean Mortality 
= 1.6% 
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Figure 5-4 Control Chart for mortality rate (percent) by lot number (sequentially 
numbered by arrival date; n=572 lots [70,010 animals]) within a commercial feedlot located 
in Kansas (KAN4); placed from January 2009 through June 2011)). Mean mortality rate = 
0.5%, SD=1.0, and upper control limit (i.e. Mean + 3 SD) = 3.6%  
 
 
Upper Control Limit = 5.0% 
Mean Mortality 
= 1.0% 
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Figure 5-5 Control Chart for mortality rate (percent) by lot number (sequentially 
numbered by arrival date; n=315 lots [59,984 animals]) within a commercial feedlot located 
in Nebraska (NEB1); placed from January 2009 through May 2011)). Mean mortality rate 
= 0.2%, SD=0.5, and upper control limit (i.e. Mean + 3 SD) = 1.8% 
 
  
 
Upper Control Limit = 1.8% 
Mean Mortality 
= 0.5% 
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Figure 5-6 Control Chart for mortality rate (percent) by lot number (sequentially 
numbered by arrival date; n=219 lots [35,452 animals]) within a commercial feedlot located 
in Nebraska (NEB2); placed from January 2009 through June 2011)). Mean mortality rate 
= 0.4%, SD=0.9, and upper control limit (i.e. Mean + 3 SD) = 3.2%  
 
 
 
Upper Control Limit = 3.2% 
Mean Mortality 
= 0.4% 
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Figure 5-7 Control Chart for mortality rate (percent) by lot number (sequentially 
numbered by arrival date; n=943 lots [42,266 animals]) within a commercial feedlot located 
in Nebraska (NEB3); placed from January 2009 through July 2011)). Mean mortality rate 
= 0.4%, SD=0.9, and upper control limit (i.e. Mean + 3 SD) = 3.2% 
 
 
 
Upper Control  
Limit = 3.2% 
Mean  
Mortality=0.4% 
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Figure 5-8 Control Chart for mortality rate (percent) by lot number (sequentially 
numbered by arrival date) within two commercial feedlots located in Kansas (KAN02 
[n=286 lots (24,595 animals); and KAN03 [n=219 lots [27,328 animals]); placed from 
January 2009 through July 2011).  Mean mortality rate was less in KAN02 ( =0.13%; 
SD=0.69; UCL = 2.23%) compared with KAN03 ( =1.10%; SD=1.99; UCL = 7.08%). 
 
 
 
 
KAN02 KAN03 
UCL from 
KAN02 = 
2.23% 
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Appendix A - Clinical Score Scale for animals with BRDC 
  
 
            
  Score Description   
  
0 Normal:  Nothing unusual in animal’s attitude and no abnormal 
respiratory symptoms present.    
  
1 Mild depression (somewhat slow coming to feed bunk, but did 
eat).  Mild respiratory symptoms present; serous nasal or ocular 
discharge and/or cough.   
  
2 Moderate depression (slight head/ears dropping, reluctant to move 
about, reluctant to come to the feed bunk).  Moderate respiratory 
distress:  Mucosus or mucopurulent nasal or ocular discharge 
and/or increase in respiratory rate or effort.   
  
3 Severe depression (pronounced head/ear droop’ very reluctant to 
move).  Severe respiratory distress: marked increase in respiratory 
rate or effort including: open mouth breathing, abdominal 
breathing, or extended head)   
  4 Moribund   
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